Multiple	O
transcription	B-protein
factors	I-protein
are	O
required	O
for	O
activation	O
of	O
human	B-DNA
interleukin	I-DNA
9	I-DNA
gene	I-DNA
in	O
T	B-cell_type
cells	I-cell_type
.	O

The	O
genetic	O
elements	O
and	O
regulatory	O
mechanisms	O
responsible	O
for	O
human	B-DNA
interleukin	I-DNA
9	I-DNA
(	I-DNA
IL-9	I-DNA
)	I-DNA
gene	I-DNA
expression	O
in	O
a	O
human	B-cell_line
T	I-cell_line
cell	I-cell_line
leukemia	I-cell_line
virus	I-cell_line
type	I-cell_line
I-transformed	I-cell_line
human	I-cell_line
T	I-cell_line
cell	I-cell_line
line	I-cell_line
,	O
C5MJ2	B-cell_line
,	O
were	O
investigated	O
.	O

We	O
demonstrated	O
that	O
IL-9	B-DNA
gene	I-DNA
expression	O
is	O
controlled	O
,	O
at	O
least	O
in	O
part	O
,	O
by	O
transcriptional	O
activation	O
.	O

Transient	O
expression	O
of	O
the	O
luciferase	B-DNA
reporter	I-DNA
gene	I-DNA
linked	O
to	O
serially	O
deleted	O
sequences	O
of	O
the	O
5'-flanking	B-DNA
region	I-DNA
of	O
the	O
IL-9	B-DNA
gene	I-DNA
has	O
revealed	O
several	O
positive	O
and	O
negative	B-DNA
regulatory	I-DNA
elements	I-DNA
involved	O
in	O
the	O
basal	O
and	O
inducible	O
expression	O
of	O
the	O
IL-9	B-DNA
gene	I-DNA
in	O
C5MJ2	B-cell_line
cells	I-cell_line
.	O

An	O
AP-1	O
site	O
at	O
-146	O
to	O
-140	O
was	O
shown	O
to	O
be	O
involved	O
in	O
the	O
expression	O
of	O
the	O
IL-9	B-DNA
gene	I-DNA
.	O

A	O
proximal	B-DNA
region	I-DNA
between	O
-46	B-DNA
and	I-DNA
-80	I-DNA
was	O
identified	O
as	O
the	O
minimum	O
sequence	O
for	O
the	O
basal	O
and	O
inducible	O
expression	O
of	O
the	O
IL-9	B-DNA
gene	I-DNA
in	O
C5MJ2	B-cell_line
cells	I-cell_line
.	O

Within	O
this	O
region	O
,	O
an	O
NF-kappaB	B-DNA
site	I-DNA
at	O
-59	B-DNA
to	I-DNA
-50	I-DNA
and	O
its	O
adjacent	O
20-base	B-DNA
pair	I-DNA
upstream	I-DNA
sequence	I-DNA
were	O
demonstrated	O
to	O
play	O
a	O
critical	O
role	O
for	O
the	O
IL-9	B-DNA
promoter	I-DNA
activity	O
.	O

DNA-protein	O
binding	O
studies	O
indicated	O
that	O
NF-kappaB	B-protein
,	O
c-Jun	B-protein
,	O
and	O
potentially	O
novel	B-protein
proteins	I-protein
(	O
around	O
35	B-protein
kDa	I-protein
)	O
can	O
bind	O
to	O
this	O
important	O
sequence	O
.	O

Mutations	O
at	O
different	O
sites	O
within	O
this	O
proximal	B-DNA
promoter	I-DNA
region	I-DNA
abolished	O
the	O
promoter	O
activity	O
as	O
well	O
as	O
the	O
DNA	O
binding	O
.	O

Taken	O
together	O
,	O
these	O
results	O
suggest	O
that	O
the	O
cooperation	O
of	O
different	O
transcription	B-protein
factors	I-protein
is	O
essential	O
for	O
IL-9	B-DNA
gene	I-DNA
expression	O
in	O
T	B-cell_type
cells	I-cell_type
.	O

THs	NULL
JourNaL	NULL
or	NULL
BroLocicaL	NULL
CHEMISTRY	NULL
©	NULL
1996	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

271	NULL
,	NULL
No	NULL
.	NULL

26	NULL
,	NULL
Issue	NULL
of	NULL
June	NULL
28	NULL
,	NULL
pp	NULL
.	NULL

15815-15822	NULL
,	NULL
1996	NULL
Printed	NULL
in	NULL
U.S.A	NULL
.	NULL

Multiple	NULL
Transcription	NULL
Factors	NULL
Are	NULL
Required	NULL
for	NULL
Activation	NULL
of	NULL
Human	NULL
Interleukin	NULL
9	NULL
Gene	NULL
in	NULL
T	NULL
Cells*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
December	NULL
22	NULL
,	NULL
1995	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
March	NULL
12	NULL
,	NULL
1996	NULL
)	NULL
Yuan	NULL
Xiao	NULL
Zhut§	NULL
,	NULL
Li	NULL
Ya	NULL
Kang	NULL
$	NULL
§	NULL
,	NULL
Wen	NULL
Luo	NULL
,	NULL
Chou-Chi	NULL
H.	NULL
Li	NULL
]	NULL
,	NULL
Liu	NULL
Yang1	NULL
,	NULL
and	NULL
Yu-Chung	NULL
Yangt§t**	NULL
From	NULL
the	NULL
{	NULL
Walther	NULL
Oncology	NULL
Center	NULL
,	NULL
§Department	NULL
of	NULL
Medicine	NULL
(	NULL
Hematology	NULL
/Oncology	NULL
)	NULL
,	NULL
and	NULL
(	NULL
Department	NULL
of	NULL
Biochemistry	NULL
/	NULL
Molecular	NULL
Biology	NULL
,	NULL
Indiana	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Indianapolis	NULL
,	NULL
Indiana	NULL
46202	NULL
and	NULL
the	NULL
Biological	NULL
Carcinogenis	NULL
and	NULL
Development	NULL
Program	NULL
,	NULL
SAIC	NULL
/Frederick	NULL
,	NULL
NCI-Frederick	NULL
Cancer	NULL
Research	NULL
and	NULL
Development	NULL
Center	NULL
,	NULL
Frederick	NULL
,	NULL
Maryland	NULL
21702-1201	NULL
The	NULL
genetic	NULL
elements	NULL
and	NULL
regulatory	NULL
mechanisms	NULL
responsible	NULL
for	NULL
human	NULL
interleukin	NULL
9	NULL
(	NULL
IL-9	NULL
)	NULL
gene	NULL
expression	NULL
in	NULL
a	NULL
human	NULL
T	NULL
cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I-transformed	NULL
human	NULL
T	NULL
cell	NULL
line	NULL
,	NULL
C5MJ2	NULL
,	NULL
were	NULL
investigated	NULL
.	NULL

We	NULL
demonstrated	NULL
that	NULL
IL-9	NULL
gene	NULL
expression	NULL
is	NULL
controlled	NULL
,	NULL
at	NULL
least	NULL
in	NULL
part	NULL
,	NULL
by	NULL
transcriptional	NULL
activation	NULL
.	NULL

Transient	NULL
expression	NULL
of	NULL
the	NULL
luciferase	NULL
reporter	NULL
gene	NULL
linked	NULL
to	NULL
serially	NULL
deleted	NULL
sequences	NULL
of	NULL
the	NULL
5'-flanking	NULL
region	NULL
of	NULL
the	NULL
IL-9	NULL
gene	NULL
has	NULL
revealed	NULL
several	NULL
positive	NULL
and	NULL
negative	NULL
regulatory	NULL
elements	NULL
involved	NULL
in	NULL
the	NULL
basal	NULL
and	NULL
inducible	NULL
expression	NULL
of	NULL
the	NULL
IL-9	NULL
gene	NULL
in	NULL
C5MJ2	NULL
cells	NULL
.	NULL

An	NULL
AP-1	NULL
site	NULL
at	NULL
-146	NULL
to	NULL
-140	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
IL-9	NULL
gene	NULL
.	NULL

A	NULL
proximal	NULL
region	NULL
between	NULL
-46	NULL
and	NULL
-80	NULL
was	NULL
identified	NULL
as	NULL
the	NULL
minimum	NULL
sequence	NULL
for	NULL
the	NULL
basal	NULL
and	NULL
inducible	NULL
expression	NULL
of	NULL
the	NULL
IL-9	NULL
gene	NULL
in	NULL
C5MJ2	NULL
cells	NULL
.	NULL

Within	NULL
this	NULL
region	NULL
,	NULL
an	NULL
site	NULL
at	NULL
-59	NULL
to	NULL
-50	NULL
and	NULL
its	NULL
adjacent	NULL
20-base	NULL
pair	NULL
upstream	NULL
sequence	NULL
were	NULL
demonstrated	NULL
to	NULL
play	NULL
a	NULL
critical	NULL
role	NULL
for	NULL
the	NULL
IL-9	NULL
promoter	NULL
activity	NULL
.	NULL

DNA-protein	NULL
binding	NULL
studies	NULL
indicated	NULL
that	NULL
NF-KB	NULL
,	NULL
c-Jun	NULL
,	NULL
and	NULL
potentially	NULL
novel	NULL
proteins	NULL
(	NULL
around	NULL
35	NULL
kDa	NULL
)	NULL
can	NULL
bind	NULL
to	NULL
this	NULL
important	NULL
sequence	NULL
.	NULL

Mutations	NULL
at	NULL
different	NULL
sites	NULL
within	NULL
this	NULL
proximal	NULL
promoter	NULL
region	NULL
abolished	NULL
the	NULL
promoter	NULL
activity	NULL
as	NULL
well	NULL
as	NULL
the	NULL
DNA	NULL
binding	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
cooperation	NULL
of	NULL
different	NULL
transcription	NULL
factors	NULL
is	NULL
essential	NULL
for	NULL
IL-9	NULL
gene	NULL
expression	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Interleukin	NULL
9	NULL
(	NULL
IL-9	NULL
)	NULL
is	NULL
a	NULL
T	NULL
cell-derived	NULL
cytokine	NULL
with	NULL
pleio-tropic	NULL
activities	NULL
on	NULL
various	NULL
cell	NULL
types	NULL
(	NULL
1	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
IL-9	NULL
is	NULL
detectable	NULL
mainly	NULL
in	NULL
activated	NULL
CD4+	NULL
helper	NULL
T	NULL
cells	NULL
(	NULL
2	NULL
,	NULL
3	NULL
)	NULL
.	NULL

The	NULL
targets	NULL
of	NULL
IL-9	NULL
include	NULL
T	NULL
cells	NULL
(	NULL
1	NULL
,	NULL
4	NULL
)	NULL
,	NULL
B	NULL
cells	NULL
(	NULL
5	NULL
,	NULL
6	NULL
)	NULL
,	NULL
mast	NULL
cells	NULL
(	NULL
7	NULL
,	NULL
8	NULL
)	NULL
,	NULL
erythroid	NULL
and	NULL
myeloid	NULL
precursors	NULL
(	NULL
9	NULL
,	NULL
10	NULL
)	NULL
,	NULL
and	NULL
fetal	NULL
thy-mocytes	NULL
(	NULL
11	NULL
)	NULL
.	NULL

It	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
IL-9	NULL
can	NULL
promote	NULL
the	NULL
proliferation	NULL
of	NULL
activated	NULL
and	NULL
transformed	NULL
T	NULL
cells	NULL
,	NULL
the	NULL
production	NULL
of	NULL
immunoglobulins	NULL
by	NULL
B	NULL
cells	NULL
,	NULL
the	NULL
proliferation	NULL
and	NULL
differentiation	NULL
of	NULL
mast	NULL
cells	NULL
,	NULL
and	NULL
erythroid	NULL
progenitors	NULL
.	NULL

The	NULL
involvement	NULL
of	NULL
IL-9	NULL
in	NULL
tumorigenesis	NULL
has	NULL
also	NULL
been	NULL
suggested	NULL
,	NULL
since	NULL
:	NULL
1	NULL
)	NULL
the	NULL
preferential	NULL
expression	NULL
of	NULL
IL-9	NULL
was	NULL
found	NULL
in	NULL
cell	NULL
lines	NULL
derived	NULL
from	NULL
patients	NULL
with	NULL
Hodgkin	NULL
's	NULL
disease	NULL
and	NULL
ana	NULL
*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
United	NULL
States	NULL
Public	NULL
Health	NULL
Service	NULL
Grants	NULL
RO1DK43105	NULL
and	NULL
RO1HL48819	NULL
(	NULL
to	NULL
Y.-C	NULL
.	NULL

Y	NULL
.	NULL
)	NULL

.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertise-ment	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

**	NULL
Scholar	NULL
of	NULL
the	NULL
Leukemia	NULL
Society	NULL
of	NULL
America	NULL
.	NULL

To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

*	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
IL	NULL
,	NULL
interleukin	NULL
;	NULL
GM-CSF	NULL
,	NULL
granulocyte/	NULL
macrophage	NULL
colony-stimulating	NULL
factor	NULL
;	NULL
PCR	NULL
,	NULL
polymerase	NULL
chain	NULL
reaction	NULL
;	NULL
Ab	NULL
,	NULL
antibody	NULL
;	NULL
CRE	NULL
,	NULL
cAMP	NULL
response	NULL
element	NULL
;	NULL
CREB	NULL
,	NULL
CRE-binding	NULL
pro-tein	NULL
;	NULL
B-gal	NULL
,	NULL
B-galactosidase	NULL
;	NULL
TPA	NULL
,	NULL
12-O-tetradecanoylphorbol-13-ace-tate	NULL
;	NULL
PHA	NULL
,	NULL
phytohemagglutinin	NULL
.	NULL

plastic	NULL
large	NULL
cell	NULL
lymphoma	NULL
(	NULL
12	NULL
,	NULL
13	NULL
)	NULL
,	NULL
2	NULL
)	NULL
IL-9	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
a	NULL
proliferation	NULL
inducer	NULL
and	NULL
a	NULL
major	NULL
anti-apoptotic	NULL
factor	NULL
for	NULL
mouse	NULL
thymic	NULL
lymphomas	NULL
(	NULL
14	NULL
,	NULL
15	NULL
)	NULL
,	NULL
and	NULL
3	NULL
)	NULL
the	NULL
ratio	NULL
of	NULL
occurrence	NULL
of	NULL
lymphoma	NULL
by	NULL
mutagen	NULL
or	NULL
x-ray	NULL
irradiation	NULL
increased	NULL
dramatically	NULL
in	NULL
transgenic	NULL
mice	NULL
with	NULL
dysregulated	NULL
expression	NULL
of	NULL
IL-9	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
is	NULL
important	NULL
to	NULL
unveil	NULL
the	NULL
mechanisms	NULL
of	NULL
IL-9	NULL
gene	NULL
regulation	NULL
in	NULL
the	NULL
hematopoietic	NULL
system	NULL
.	NULL

Although	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
the	NULL
production	NULL
of	NULL
IL-9	NULL
in	NULL
T	NULL
cells	NULL
can	NULL
be	NULL
induced	NULL
by	NULL
mitogen	NULL
phorbol	NULL
ester	NULL
or	NULL
anti-CD3	NULL
antibody	NULL
(	NULL
3	NULL
)	NULL
,	NULL
little	NULL
is	NULL
known	NULL
about	NULL
the	NULL
control	NULL
mechanisms	NULL
of	NULL
IL-9	NULL
expression	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
.	NULL

Human	NULL
IL-9	NULL
gene	NULL
has	NULL
been	NULL
mapped	NULL
to	NULL
the	NULL
long	NULL
arm	NULL
of	NULL
chromosome	NULL
5	NULL
at	NULL
5q31-32	NULL
(	NULL
17	NULL
,	NULL
18	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
human	NULL
IL-3	NULL
,	NULL
IL-4	NULL
,	NULL
IL-5	NULL
,	NULL
GM-CSF	NULL
,	NULL
and	NULL
IL-13	NULL
gene	NULL
clusters	NULL
have	NULL
also	NULL
been	NULL
localized	NULL
to	NULL
the	NULL
same	NULL
locus	NULL
(	NULL
19	NULL
,	NULL
20	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
IL-3	NULL
,	NULL
IL-4	NULL
,	NULL
GM-CSF	NULL
,	NULL
and	NULL
IL-5	NULL
has	NULL
been	NULL
well	NULL
studied	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
systems	NULL
.	NULL

Certain	NULL
portions	NULL
within	NULL
the	NULL
promoter	NULL
regions	NULL
of	NULL
these	NULL
genes	NULL
were	NULL
found	NULL
to	NULL
be	NULL
highly	NULL
conserved	NULL
,	NULL
and	NULL
a	NULL
common	NULL
regulatory	NULL
mechanism	NULL
was	NULL
suggested	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
coordinated	NULL
expression	NULL
of	NULL
these	NULL
cytokines	NULL
in	NULL
certain	NULL
cell	NULL
types	NULL
(	NULL
21	NULL
,	NULL
22	NULL
)	NULL
.	NULL

It	NULL
was	NULL
noted	NULL
that	NULL
the	NULL
5'-flanking	NULL
region	NULL
of	NULL
the	NULL
IL-9	NULL
gene	NULL
contains	NULL
several	NULL
putative	NULL
transcriptional	NULL
elements	NULL
,	NULL
some	NULL
of	NULL
which	NULL
are	NULL
also	NULL
identified	NULL
in	NULL
the	NULL
promoter	NULL
regions	NULL
of	NULL
other	NULL
cytokine	NULL
genes	NULL
mapped	NULL
to	NULL
the	NULL
same	NULL
chromosomal	NULL
location	NULL
(	NULL
3	NULL
,	NULL
18	NULL
)	NULL
.	NULL

However	NULL
,	NULL
unlike	NULL
other	NULL
cy-tokines	NULL
,	NULL
up	NULL
to	NULL
now	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
IL-9	NULL
gene	NULL
has	NULL
only	NULL
been	NULL
detected	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

To	NULL
understand	NULL
the	NULL
basis	NULL
of	NULL
the	NULL
T	NULL
cell-restricted	NULL
expression	NULL
of	NULL
IL-9	NULL
,	NULL
we	NULL
undertook	NULL
the	NULL
characterization	NULL
of	NULL
IL-9	NULL
upstream	NULL
regulatory	NULL
sequences	NULL
.	NULL

Our	NULL
previous	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
a	NULL
0.9-kilobase	NULL
Smal-Sacl	NULL
fragment	NULL
of	NULL
the	NULL
5'-flanking	NULL
region	NULL
of	NULL
the	NULL
IL-9	NULL
gene	NULL
contains	NULL
the	NULL
DNA	NULL
sequences	NULL
required	NULL
for	NULL
the	NULL
basal	NULL
and	NULL
inducible	NULL
expression	NULL
of	NULL
the	NULL
IL-9	NULL
gene	NULL
in	NULL
a	NULL
human	NULL
T	NULL
cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I-transformed	NULL
T	NULL
cell	NULL
line	NULL
,	NULL
C5MJ2	NULL
(	NULL
18	NULL
)	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
further	NULL
defined	NULL
the	NULL
cis-acting	NULL
DNA	NULL
elements	NULL
and	NULL
characterized	NULL
the	NULL
trans-acting	NULL
transcription	NULL
factors	NULL
involved	NULL
in	NULL
IL-9	NULL
expression	NULL
following	NULL
12-O-tetradecanoylphorbol-13-ace-tate	NULL
(	NULL
TPA	NULL
)	NULL
/phytohemagglutinin	NULL
(	NULL
PHA	NULL
)	NULL
stimulation	NULL
.	NULL

By	NULL
using	NULL
deletion	NULL
and	NULL
site-directed	NULL
mutagenesis	NULL
,	NULL
we	NULL
identified	NULL
several	NULL
DNA	NULL
sequences	NULL
in	NULL
the	NULL
5'-flanking	NULL
region	NULL
of	NULL
the	NULL
IL-9	NULL
gene	NULL
as	NULL
important	NULL
regulatory	NULL
elements	NULL
.	NULL

Several	NULL
transcription	NULL
factors	NULL
,	NULL
including	NULL
AP-1	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
and	NULL
potentially	NULL
novel	NULL
DNA-binding	NULL
proteins	NULL
(	NULL
around	NULL
35	NULL
kDa	NULL
)	NULL
,	NULL
were	NULL
found	NULL
to	NULL
play	NULL
critical	NULL
roles	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
IL-9	NULL
gene	NULL
expression	NULL
in	NULL
C5MJ2	NULL
cells	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Northern	NULL
Blot	NULL
Analysis	NULL
and	NULL
Nuclear	NULL
Run-on	NULL
Assays-Total	NULL
RNA	NULL
from	NULL
C5MJ2	NULL
cells	NULL
were	NULL
prepared	NULL
at	NULL
various	NULL
time	NULL
points	NULL
after	NULL
stimulation	NULL
with	NULL
TPA	NULL
(	NULL
§	NULL
ng/ml	NULL
!	NULL
)	NULL

and	NULL
PHA	NULL
(	NULL
10	NULL
ug/ml	NULL
)	NULL
(	NULL
23	NULL
)	NULL
.	NULL

10	NULL
pg	NULL
of	NULL
total	NULL
RNA	NULL
was	NULL
used	NULL
for	NULL
Northern	NULL
blot	NULL
and	NULL
hybridized	NULL
with	NULL
a	NULL
*°P-labeled	NULL
IL-9	NULL
cDNA	NULL
probe	NULL
.	NULL

A	NULL
human	NULL
B-actin	NULL
cDNA	NULL
probe	NULL
was	NULL
hybridized	NULL
to	NULL
the	NULL
same	NULL
filter	NULL
to	NULL
ensure	NULL
equal	NULL
loading	NULL
in	NULL
each	NULL
lane	NULL
.	NULL

The	NULL
expression	NULL
level	NULL
of	NULL
the	NULL
IL-9	NULL
message	NULL
was	NULL
quantitated	NULL
by	NULL
densitometric	NULL
scanning	NULL
of	NULL
IL-9	NULL
signal	NULL
15815	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
15816	NULL
TPA	NULL
+	NULL
PHA	NULL
TPA	NULL
+	NULL
PHA	NULL
o	NULL
4+	NULL
©	NULL
-	NULL
a	NULL
o	NULL
-	NULL
m	NULL
is	NULL
a	NULL
--	NULL
4.4	NULL
kb	NULL
wume	NULL
||	NULL
cums	NULL
-	NULL
GM-CSF	NULL
cuase	NULL
wenn	NULL
.	NULL

|L_9	NULL
B-actin	NULL
-	NULL
38	NULL
kg	NULL
-	NULL
perses	NULL
lL-9	NULL
.	NULL

.	NULL

.	NULL

%	NULL
i	NULL
f-actin	NULL
-	NULL
0.6	NULL
kb	NULL
-m-	NULL
mANA	NULL
-g-	NULL
run-on	NULL
Induction	NULL
Folds	NULL
722	NULL
.	NULL

24	NULL
2	NULL
4	NULL
5	NULL
10	NULL
12	NULL
6	NULL
TPA/PHA	NULL
(	NULL
hours	NULL
)	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Kinetics	NULL
of	NULL
IL-9	NULL
mRNA	NULL
accumulation	NULL
and	NULL
transcriptional	NULL
activation	NULL
in	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
stimulated	NULL
with	NULL
TPA	NULL
(	NULL
5	NULL
ng/ml	NULL
)	NULL
/PHA	NULL
(	NULL
10	NULL
ug/m	NULL
!	NULL
)	NULL

for	NULL
the	NULL
indicated	NULL
time	NULL
period	NULL
.	NULL

Total	NULL
RNAs	NULL
were	NULL
analyzed	NULL
for	NULL
IL-9	NULL
expression	NULL
by	NULL
Northern	NULL
analysis	NULL
,	NULL
and	NULL
the	NULL
nuclei	NULL
were	NULL
isolated	NULL
for	NULL
the	NULL
nuclear	NULL
run-on	NULL
assay	NULL
.	NULL

A	NULL
,	NULL
Northern	NULL
blot	NULL
analysis	NULL
.	NULL

10	NULL
ug	NULL
of	NULL
RNA	NULL
from	NULL
C5MJ2	NULL
cells	NULL
was	NULL
used	NULL
to	NULL
hybridize	NULL
to	NULL
a	NULL
``	NULL
°P-labeled	NULL
IL-9	NULL
cDNA	NULL
probe	NULL
,	NULL
and	NULL
then	NULL
to	NULL
a	NULL
human	NULL
G-actin	NULL
probe	NULL
.	NULL

B	NULL
,	NULL
nuclear	NULL
run-on	NULL
assay	NULL
.	NULL

3	NULL
X	NULL
10	NULL
``	NULL
C5MJ2	NULL
nuclei	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

5	NULL
X	NULL
10°	NULL
cpm	NULL
transcripts	NULL
were	NULL
hybridized	NULL
to	NULL
5	NULL
ug	NULL
of	NULL
denatured	NULL
plasmid	NULL
DNAs	NULL
containing	NULL
specific	NULL
and	NULL
nonspecific	NULL
inserts	NULL
immobilized	NULL
on	NULL
nylon	NULL
membranes	NULL
.	NULL

C	NULL
,	NULL
kinetics	NULL
of	NULL
Northern	NULL
blot	NULL
and	NULL
run-on	NULL
analysis	NULL
.	NULL

Induction	NULL
folds	NULL
were	NULL
calculated	NULL
according	NULL
to	NULL
the	NULL
densitometric	NULL
scanning	NULL
of	NULL
IL-9	NULL
signals	NULL
versus	NULL
-actin	NULL
signals	NULL
.	NULL

relative	NULL
to	NULL
that	NULL
of	NULL
the	NULL
-actin	NULL
internal	NULL
control	NULL
.	NULL

For	NULL
nuclear	NULL
run-on	NULL
assays	NULL
,	NULL
the	NULL
labeled	NULL
run-on	NULL
transcripts	NULL
from	NULL
3	NULL
X	NULL
10	NULL
``	NULL
C5MJ2	NULL
cells	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
24	NULL
)	NULL
.	NULL

5	NULL
ug	NULL
of	NULL
plasmids	NULL
containing	NULL
the	NULL
inserts	NULL
for	NULL
human	NULL
GM-CSF	NULL
(	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
)	NULL
,	NULL
human	NULL
IL-9	NULL
,	NULL
human	NULL
-actin	NULL
,	NULL
and	NULL
pBR822	NULL
(	NULL
no	NULL
insert	NULL
)	NULL
were	NULL
slot-blotted	NULL
onto	NULL
nylon	NULL
membranes	NULL
and	NULL
hybridized	NULL
with	NULL
the	NULL
same	NULL
amount	NULL
of	NULL
labeled	NULL
run-on	NULL
products	NULL
.	NULL

Primer	NULL
Extension	NULL
,	NULL
RNase	NULL
Protection	NULL
,	NULL
and	NULL
DNA	NULL
Sequencing-The	NULL
transcriptional	NULL
initiation	NULL
site	NULL
of	NULL
human	NULL
IL-9	NULL
in	NULL
C5MJ2	NULL
cells	NULL
was	NULL
determined	NULL
by	NULL
both	NULL
primer	NULL
extension	NULL
and	NULL
RNase	NULL
protection	NULL
methods	NULL
as	NULL
described	NULL
(	NULL
25	NULL
)	NULL
.	NULL

For	NULL
the	NULL
primer	NULL
extension	NULL
assay	NULL
,	NULL
50	NULL
ug	NULL
of	NULL
C5MJ2	NULL
total	NULL
RNA	NULL
was	NULL
hybridized	NULL
to	NULL
1	NULL
X	NULL
10°	NULL
cpm	NULL
of	NULL
a	NULL
*°P-labeled	NULL
oligonucleotide	NULL
primer	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
the	NULL
synthetic	NULL
35-base	NULL
oligonucleotide	NULL
primer	NULL
is	NULL
5'-TGGCCTGCCACGGAGCACAGGAGCAGGGCAGAGGT-3	NULL
'	NULL
,	NULL
which	NULL
is	NULL
complementary	NULL
to	NULL
a	NULL
region	NULL
within	NULL
the	NULL
first	NULL
exon	NULL
of	NULL
the	NULL
human	NULL
IL-9	NULL
gene	NULL
(	NULL
18	NULL
)	NULL
.	NULL

The	NULL
antisense	NULL
RNA	NULL
probe	NULL
for	NULL
the	NULL
RNase	NULL
protection	NULL
assay	NULL
was	NULL
generated	NULL
by	NULL
in	NULL
vitro	NULL
transcription	NULL
of	NULL
Scal-linearized	NULL
p5928	NULL
(	NULL
18	NULL
)	NULL
using	NULL
T7	NULL
RNA	NULL
polymerase	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
26	NULL
)	NULL
1	NULL
x	NULL
10°	NULL
cpm	NULL
of	NULL
antisense	NULL
RNA	NULL
probe	NULL
was	NULL
hybridized	NULL
to	NULL
50	NULL
ug	NULL
of	NULL
C5SMJ2	NULL
total	NULL
RNA	NULL
.	NULL

The	NULL
RNA-RNA	NULL
hybrids	NULL
were	NULL
treated	NULL
with	NULL
RNase	NULL
A	NULL
and	NULL
RNase	NULL
T1	NULL
,	NULL
followed	NULL
by	NULL
proteinase	NULL
K	NULL
digestion	NULL
,	NULL
and	NULL
finally	NULL
fractionated	NULL
on	NULL
an	NULL
8	NULL
%	NULL
urea	NULL
sequencing	NULL
gel	NULL
.	NULL

Plasmid	NULL
Construction-DNA	NULL
fragments	NULL
containing	NULL
various	NULL
portions	NULL
of	NULL
the	NULL
5'-flanking	NULL
region	NULL
of	NULL
the	NULL
human	NULL
IL-9	NULL
gene	NULL
were	NULL
generated	NULL
either	NULL
by	NULL
restriction	NULL
endonuclease	NULL
digestion	NULL
or	NULL
by	NULL
polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
PCR	NULL
)	NULL
and	NULL
were	NULL
subcloned	NULL
into	NULL
the	NULL
Smal/Sacl	NULL
sites	NULL
of	NULL
pXP2	NULL
,	NULL
a	NULL
firefly	NULL
luciferase	NULL
reporter	NULL
gene	NULL
expression	NULL
vector	NULL
(	NULL
27	NULL
)	NULL
.	NULL

The	NULL
nested	NULL
deletion	NULL
constructs	NULL
were	NULL
designated	NULL
as	NULL
plasmids	NULL
pIL-9-D1	NULL
to	NULL
pIL-9-D18	NULL
.	NULL

The	NULL
exact	NULL
position	NULL
(	NULL
relative	NULL
to	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
)	NULL
of	NULL
deletion	NULL
in	NULL
each	NULL
construct	NULL
is	NULL
shown	NULL
in	NULL
Figs	NULL
.	NULL

3	NULL
and	NULL
6A	NULL
.	NULL

Other	NULL
mutation	NULL
constructs	NULL
,	NULL
such	NULL
as	NULL
pIL-9-M1	NULL
to	NULL
pIL-9-M4	NULL
,	NULL
pIL-9-AP1w	NULL
,	NULL
and	NULL
pIL-9-AP1m	NULL
,	NULL
were	NULL
generated	NULL
by	NULL
PCR	NULL
and	NULL
confirmed	NULL
by	NULL
DNA	NULL
sequencing	NULL
.	NULL

Transient	NULL
Transfection	NULL
and	NULL
Luciferase	NULL
Assay-C5GMI2	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
RPMI	NULL
medium	NULL
supplemented	NULL
with	NULL
5	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
to	NULL
the	NULL
density	NULL
of	NULL
5	NULL
X	NULL
10	NULL
%	NULL
/ml	NULL
.	NULL

Transient	NULL
transfection	NULL
of	NULL
C5MJ2	NULL
cells	NULL
was	NULL
performed	NULL
by	NULL
electroporation	NULL
with	NULL
a	NULL
Bio-Rad	NULL
Gene	NULL
Pulser	NULL
.	NULL

5	NULL
pg	NULL
of	NULL
each	NULL
promoter-reporter	NULL
construct	NULL
plus	NULL
1	NULL
ug	NULL
of	NULL
the	NULL
pCMV-B-gal	NULL
reference	NULL
plasmid	NULL
were	NULL
mixed	NULL
with	NULL
1	NULL
x	NULL
10	NULL
``	NULL
C5MJ2	NULL
cells	NULL
in	NULL
0.3	NULL
ml	NULL
of	NULL
medium	NULL
and	NULL
transferred	NULL
into	NULL
a	NULL
0.4-cm	NULL
cuvette	NULL
.	NULL

Following	NULL
a	NULL
single	NULL
200-V/960-micro-	NULL
Transcriptional	NULL
Regulation	NULL
of	NULL
IL-9	NULL
Gene	NULL
Expression	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
&	NULL
elif	NULL
Fd	NULL
48	NULL
,	NULL
~	NULL
``	NULL
#	NULL
GEE	NULL
a\	NULL
&	NULL
99	NULL
Tx-	NULL
G	NULL
I	NULL
I\	NULL
@	NULL
$	NULL
_	NULL
¢	NULL
~	NULL
<	NULL
-	NULL
c	NULL
Q	NULL
’	NULL
f—	NULL
ya	NULL
8	NULL
as	NULL
Lond	NULL
A	NULL
a	NULL
#	NULL
C	NULL
6	NULL
£	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

5	NULL
mapping	NULL
of	NULL
the	NULL
IL-9	NULL
mRNA	NULL
.	NULL

The	NULL
5'-end	NULL
of	NULL
the	NULL
human	NULL
IL-9	NULL
mRNA	NULL
was	NULL
determined	NULL
by	NULL
primer	NULL
extension	NULL
and	NULL
RNase	NULL
protection	NULL
assays	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

DNA	NULL
ladders	NULL
(	NULL
lanes	NULL
1-4	NULL
)	NULL
were	NULL
generated	NULL
by	NULL
sequencing	NULL
IL-9	NULL
genomic	NULL
DNA	NULL
.	NULL

The	NULL
same	NULL
primer	NULL
used	NULL
for	NULL
sequencing	NULL
was	NULL
hybridized	NULL
to	NULL
unstimulated	NULL
(	NULL
Jane	NULL
5	NULL
)	NULL
or	NULL
TPA/PHA-stimulated	NULL
(	NULL
Zane	NULL
6	NULL
)	NULL
C5MJ2	NULL
total	NULL
RNA	NULL
and	NULL
extended	NULL
with	NULL
reverse	NULL
transcriptase	NULL
.	NULL

The	NULL
antisense	NULL
RNA	NULL
probe	NULL
transcribed	NULL
from	NULL
IL-9	NULL
genomic	NULL
DNA	NULL
was	NULL
hybridized	NULL
to	NULL
the	NULL
total	NULL
RNA	NULL
from	NULL
unstimulated	NULL
(	NULL
Zane	NULL
7	NULL
)	NULL
or	NULL
stimulated	NULL
(	NULL
Zane	NULL
8	NULL
)	NULL
C5MJ2	NULL
cells	NULL
.	NULL

Following	NULL
digestion	NULL
with	NULL
RNase	NULL
,	NULL
the	NULL
samples	NULL
were	NULL
fractionated	NULL
on	NULL
an	NULL
8	NULL
%	NULL
sequencing	NULL
gel	NULL
.	NULL

The	NULL
mapped	NULL
transcription	NULL
start	NULL
point	NULL
,	NULL
the	NULL
overextended	NULL
primer	NULL
extension	NULL
products	NULL
,	NULL
the	NULL
RNA	NULL
fragments	NULL
protected	NULL
from	NULL
RNase	NULL
digestion	NULL
,	NULL
and	NULL
the	NULL
DNA	NULL
sequences	NULL
around	NULL
the	NULL
start	NULL
site	NULL
are	NULL
indicated	NULL
.	NULL

The	NULL
restriction	NULL
enzyme	NULL
Sacl	NULL
site	NULL
for	NULL
constructing	NULL
IL-9-luciferase	NULL
plasmids	NULL
is	NULL
under/ined	NULL
.	NULL

farad	NULL
pulse	NULL
,	NULL
each	NULL
sample	NULL
was	NULL
divided	NULL
into	NULL
two	NULL
parts	NULL
and	NULL
maintained	NULL
in	NULL
6	NULL
ml	NULL
of	NULL
medium	NULL
with	NULL
or	NULL
without	NULL
TPA	NULL
(	NULL
§	NULL
ng/ml	NULL
)	NULL
/PHA	NULL
(	NULL
10	NULL
ug/ml	NULL
)	NULL
.	NULL

24	NULL
h	NULL
after	NULL
electroporation	NULL
,	NULL
cells	NULL
were	NULL
lysed	NULL
for	NULL
luciferase	NULL
and	NULL
B-galactosidase	NULL
(	NULL
B-gal	NULL
)	NULL
assays	NULL
(	NULL
25	NULL
)	NULL
.	NULL

The	NULL
luciferase	NULL
activity	NULL
was	NULL
normalized	NULL
according	NULL
to	NULL
the	NULL
B-gal	NULL
control	NULL
.	NULL

DNA/Protein	NULL
Binding	NULL
Studies-Nuclear	NULL
protein	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
(	NULL
28	NULL
)	NULL
.	NULL

The	NULL
DNase	NULL
I	NULL
footprinting	NULL
assay	NULL
was	NULL
performed	NULL
according	NULL
to	NULL
the	NULL
standard	NULL
procedure	NULL
with	NULL
20	NULL
pg	NULL
of	NULL
nuclear	NULL
extract	NULL
and	NULL
2	NULL
x	NULL
10	NULL
%	NULL
cpm	NULL
of	NULL
a	NULL
*°P-5'-end-labeled	NULL
fragment	NULL
covering	NULL
-125	NULL
to	NULL
+8	NULL
of	NULL
the	NULL
5'-flanking	NULL
region	NULL
of	NULL
the	NULL
IL-9	NULL
gene	NULL
.	NULL

After	NULL
DNase	NULL
I	NULL
partial	NULL
digestion	NULL
and	NULL
phenol/chloroform	NULL
extraction	NULL
,	NULL
samples	NULL
were	NULL
electrophoresed	NULL
through	NULL
an	NULL
8	NULL
%	NULL
urea	NULL
sequencing	NULL
gel	NULL
.	NULL

A	NULL
sequencing	NULL
reaction	NULL
was	NULL
run	NULL
in	NULL
parallel	NULL
to	NULL
serve	NULL
as	NULL
a	NULL
reference	NULL
for	NULL
the	NULL
protected	NULL
region	NULL
.	NULL

The	NULL
gel	NULL
shift	NULL
assay	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
with	NULL
4	NULL
pug	NULL
of	NULL
the	NULL
nuclear	NULL
extract	NULL
and	NULL
2	NULL
X	NULL
10°	NULL
cpm	NULL
of	NULL
the	NULL
probe	NULL
(	NULL
29	NULL
)	NULL
.	NULL

In	NULL
gel	NULL
supershift	NULL
experiments	NULL
,	NULL
the	NULL
empirically	NULL
determined	NULL
amounts	NULL
of	NULL
antibodies	NULL
(	NULL
Abs	NULL
)	NULL
were	NULL
preincubated	NULL
,	NULL
in	NULL
parallel	NULL
with	NULL
the	NULL
same	NULL
amount	NULL
of	NULL
preimmune	NULL
serum	NULL
,	NULL
for	NULL
40	NULL
min	NULL
at	NULL
4	NULL
°C	NULL
with	NULL
the	NULL
nuclear	NULL
proteins	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
probes	NULL
.	NULL

The	NULL
following	NULL
Abs	NULL
were	NULL
used	NULL
for	NULL
gel	NULL
supershift	NULL
assays	NULL
:	NULL
anti-c-Jun/AP-1	NULL
and	NULL
anti-c-Fos/AP-1	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnol-ogy	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
anti-p50/NF-	NULL
«	NULL
B	NULL
,	NULL
anti-c-Rel/NF-xB	NULL
(	NULL
30	NULL
)	NULL
,	NULL
and	NULL
anti-CREB	NULL
(	NULL
a	NULL
gift	NULL
of	NULL
Dr.	NULL
Chou-Zen	NULL
Giam	NULL
)	NULL
.	NULL

In	NULL
peptide	NULL
and	NULL
oligonucleotide	NULL
competition	NULL
experiments	NULL
,	NULL
2	NULL
ug	NULL
of	NULL
competitor	NULL
peptides	NULL
(	NULL
30	NULL
)	NULL
or	NULL
a	NULL
50-fold	NULL
molar	NULL
excess	NULL
of	NULL
various	NULL
competitor	NULL
oligonucleotides	NULL
were	NULL
preincubated	NULL
with	NULL
Abs	NULL
or	NULL
nuclear	NULL
extracts	NULL
for	NULL
10	NULL
min	NULL
before	NULL
the	NULL
binding	NULL
reactions	NULL
.	NULL

The	NULL
sequences	NULL
of	NULL
AP-1	NULL
,	NULL
NF-kB	NULL
,	NULL
NF-AT	NULL
,	NULL
and	NULL
CRE	NULL
competitors	NULL
are	NULL
:	NULL
AP-1	NULL
,	NULL
5'-CGCTTGATGAGTCAGCCGGAA-3	NULL
'	NULL
(	NULL
Promega	NULL
)	NULL
;	NULL
NF-kB	NULL
,	NULL
5'-ACAAG-GGACTTTCCGCTGGGGACTTTCCAG-3	NULL
'	NULL
;	NULL
consensus	NULL
NF-AT	NULL
p/c	NULL
binding	NULL
motif	NULL
,	NULL
5'-GATCATTTTCCGATC-3	NULL
'	NULL
(	NULL
81	NULL
)	NULL
;	NULL
CRE	NULL
,	NULL
5'-GATCTGGGCGT-	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Transcriptional	NULL
Regulation	NULL
of	NULL
IL-9	NULL
Gene	NULL
Expression	NULL
15817	NULL
-876	NULL
-i	NULL
-683	NULL
-540	NULL
-379	NULL
-299	NULL
-213	NULL
phil-9.01	NULL
[	NULL
Z	NULL
]	NULL
unstimutated	NULL
phL-9.02	NULL
MJ	NULL
arm	NULL
phit.9.03	NULL
phiL-9.04	NULL
phiL-9.05	NULL
phiL-2.06	NULL
phIL-9.D7	NULL
phiL-9.08	NULL
phil-9.09	NULL
;	NULL
;	NULL
i	NULL
1	NULL
1	NULL
!	NULL

.	NULL

0	NULL
200	NULL
400	NULL
600	NULL
800	NULL
1,000	NULL
1,200	NULL
1,400	NULL
1,600	NULL
Relative	NULL
luciferase	NULL
activity	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Promoter	NULL
activities	NULL
of	NULL
IL-9-luciferase	NULL
deletion	NULL
constructs	NULL
in	NULL
C5MJ2	NULL
cells	NULL
.	NULL

Deletion	NULL
mutants	NULL
of	NULL
the	NULL
IL-9	NULL
5'-flanking	NULL
region	NULL
were	NULL
constructed	NULL
using	NULL
a	NULL
luciferase-based	NULL
vector	NULL
,	NULL
pXP2	NULL
,	NULL
and	NULL
transfected	NULL
into	NULL
C5SMJ2	NULL
cells	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

The	NULL
numbers	NULL
given	NULL
at	NULL
the	NULL
5	NULL
``	NULL
end	NULL
of	NULL
each	NULL
construct	NULL
represent	NULL
the	NULL
positions	NULL
in	NULL
base	NULL
pairs	NULL
relative	NULL
to	NULL
the	NULL
initiation	NULL
site	NULL
of	NULL
transcription	NULL
.	NULL

The	NULL
result	NULL
represents	NULL
the	NULL
mean	NULL
of	NULL
six	NULL
to	NULL
seven	NULL
identical	NULL
experiments	NULL
.	NULL

A	NULL
AP-iw	NULL
-	NULL
-150	NULL
5'CAAGTGACTCACTTTGAT	NULL
3-133	NULL
uNE	NULL
AP-1m	NULL
5	NULL
'	NULL
CAAGTGACTCCGTTTGAT	NULL
3	NULL
!	NULL

1200	NULL
[	NULL
_	NULL
Junstimutated	NULL
R	NULL
rowPria	NULL
1,000	NULL
I	NULL
a	NULL
3	NULL
T	NULL
Retative	NULL
luciferase	NULL
activity	NULL
§	NULL
200	NULL
|	NULL
plL-9-AP1iw	NULL
__	NULL
pllL-9-APim	NULL
ge	NULL
22	NULL
2	NULL
R2	NULL
~	NULL
sNE	NULL
-o	NULL
$	NULL
o	NULL
40	NULL
40	NULL
+	NULL
o+	NULL
#	NULL
AP-1w	NULL
+o	NULL
f	NULL
o-	NULL
$	NULL
0	NULL
+	NULL
O+	NULL
AP-1m	NULL
oe	NULL
e	NULL
Anti-c-Jun	NULL
-	NULL
-	NULL
-	NULL
-	NULL
4	NULL
Anti-c-Fos	NULL
-	NULL
-	NULL
-	NULL
-	NULL
-	NULL
+	NULL
10	NULL
2	NULL
3	NULL
4	NULL
50	NULL
6	NULL
Fic	NULL
.	NULL

4	NULL
.	NULL

Analysis	NULL
of	NULL
AP-1-like	NULL
site	NULL
at	NULL
position	NULL
-146	NULL
to	NULL
-140	NULL
of	NULL
the	NULL
-flanking	NULL
region	NULL
of	NULL
the	NULL
human	NULL
IL-9	NULL
gene	NULL
.	NULL

A	NULL
,	NULL
functional	NULL
analysis	NULL
.	NULL

The	NULL
sequences	NULL
of	NULL
5	NULL
'	NULL
primers	NULL
for	NULL
generating	NULL
the	NULL
wild	NULL
type	NULL
AP-1	NULL
construct	NULL
(	NULL
pAP-1w	NULL
)	NULL
and	NULL
the	NULL
AP-1	NULL
mutant	NULL
(	NULL
pAP-1m	NULL
)	NULL
are	NULL
shown	NULL
with	NULL
AP-1-like	NULL
binding	NULL
motif	NULL
underlined	NULL
.	NULL

pAP-1w	NULL
and	NULL
pAP-1m	NULL
were	NULL
constructed	NULL
by	NULL
the	NULL
PCR	NULL
method	NULL
and	NULL
were	NULL
transfected	NULL
into	NULL
C5MJ2	NULL
cells	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

The	NULL
mean	NULL
values	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
are	NULL
shown	NULL
.	NULL

B	NULL
,	NULL
protein	NULL
binding	NULL
study	NULL
.	NULL

Gel	NULL
shift	NULL
and	NULL
gel	NULL
supershift	NULL
assays	NULL
were	NULL
performed	NULL
with	NULL
synthesized	NULL
double-stranded	NULL
oligonucleotides	NULL
harboring	NULL
wild	NULL
type	NULL
(	NULL
AP-1w	NULL
)	NULL
or	NULL
mutated	NULL
AP-1	NULL
(	NULL
AP-1m	NULL
)	NULL
sites	NULL
.	NULL

The	NULL
sequences	NULL
of	NULL
these	NULL
oligonucleotides	NULL
are	NULL
identical	NULL
to	NULL
the	NULL
sequences	NULL
of	NULL
5	NULL
``	NULL
primers	NULL
shown	NULL
in	NULL
(	NULL
A	NULL
)	NULL
.	NULL

The	NULL
nuclear	NULL
extracts	NULL
from	NULL
unstimulated	NULL
or	NULL
TPA/PHA-stimulated	NULL
(	NULL
sNE	NULL
)	NULL
CSMJ2	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
*°P-labeled	NULL
AP-1w	NULL
or	NULL
AP-1m	NULL
probe	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
antibodies	NULL
against	NULL
c-Jun	NULL
or	NULL
c-Fos	NULL
.	NULL

The	NULL
position	NULL
of	NULL
the	NULL
specific	NULL
binding	NULL
complex	NULL
is	NULL
indicated	NULL
by	NULL
an	NULL
arrow	NULL
.	NULL

610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
15818	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
o-	NULL
-g+*	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

DNase	NULL
I	NULL
footprinting	NULL
analysis	NULL
of	NULL
the	NULL
5'-flanking	NULL
sequence	NULL
of	NULL
the	NULL
human	NULL
IL-9	NULL
gene	NULL
.	NULL

A	NULL
133-base	NULL
pair	NULL
fragment	NULL
(	NULL
base	NULL
pairs	NULL
-125	NULL
to	NULL
+8	NULL
;	NULL
sense	NULL
strand	NULL
)	NULL
was	NULL
end-labeled	NULL
and	NULL
incubated	NULL
with	NULL
(	NULL
lanes	NULL
2-4	NULL
)	NULL
or	NULL
without	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
5	NULL
)	NULL
nuclear	NULL
extract	NULL
from	NULL
stimulated	NULL
C5MJ2	NULL
cells	NULL
before	NULL
partial	NULL
digestion	NULL
with	NULL
DNase	NULL
I	NULL
.	NULL

The	NULL
protected	NULL
DNA	NULL
segment	NULL
between	NULL
-80	NULL
and	NULL
-45	NULL
is	NULL
marked	NULL
with	NULL
a	NULL
bracket	NULL
.	NULL

TGACGTCAACCCCTCACCTCAAAAAACTTTCCATGG-3	NULL
'	NULL
(	NULL
a	NULL
gift	NULL
of	NULL
Dr.	NULL
Chou-Zen	NULL
Giam	NULL
)	NULL
.	NULL

In	NULL
UV-cross-linking	NULL
and	NULL
immunoprecipitation	NULL
assays	NULL
,	NULL
the	NULL
bromode-oxyuridine	NULL
and	NULL
[	NULL
°°P	NULL
]	NULL
dCTP	NULL
were	NULL
introduced	NULL
into	NULL
the	NULL
double-stranded	NULL
DNA	NULL
covering	NULL
-76	NULL
to	NULL
-58	NULL
of	NULL
the	NULL
IL-9	NULL
5'-flanking	NULL
sequence	NULL
as	NULL
described	NULL
(	NULL
25	NULL
)	NULL
.	NULL

After	NULL
a	NULL
standard	NULL
DNA	NULL
and	NULL
protein	NULL
binding	NULL
reaction	NULL
,	NULL
the	NULL
DNA-protein	NULL
complexes	NULL
were	NULL
UV-irradiated	NULL
for	NULL
1	NULL
h	NULL
on	NULL
ice	NULL
.	NULL

For	NULL
immunoprecipitation	NULL
experiments	NULL
,	NULL
4	NULL
ug	NULL
of	NULL
Abs	NULL
or	NULL
normal	NULL
rabbit	NULL
IgG	NULL
were	NULL
added	NULL
to	NULL
each	NULL
reaction	NULL
after	NULL
UV	NULL
irradiation	NULL
.	NULL

The	NULL
precipitated	NULL
and	NULL
UV-cross-linked	NULL
proteins	NULL
were	NULL
separated	NULL
on	NULL
a	NULL
7.5	NULL
%	NULL
SDS-polyacrylamide	NULL
gel	NULL
,	NULL
transferred	NULL
to	NULL
a	NULL
nitrocellulose	NULL
membrane	NULL
,	NULL
and	NULL
exposed	NULL
to	NULL
x-ray	NULL
film	NULL
.	NULL

RESULTS	NULL
Up-regulation	NULL
of	NULL
IL-9	NULL
Gene	NULL
Expression	NULL
in	NULL
TPA/PHA-stimulated	NULL
CSMJ2	NULL
Cells-The	NULL
kinetics	NULL
of	NULL
TPA/PHA-induced	NULL
expression	NULL
of	NULL
the	NULL
human	NULL
IL-9	NULL
gene	NULL
in	NULL
C5MJ2	NULL
cells	NULL
was	NULL
examined	NULL
by	NULL
Northern	NULL
blot	NULL
analysis	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

14	NULL
,	NULL
the	NULL
steady-state	NULL
level	NULL
of	NULL
the	NULL
IL-9	NULL
mRNA	NULL
was	NULL
very	NULL
low	NULL
in	NULL
unstimulated	NULL
cells	NULL
and	NULL
can	NULL
be	NULL
transiently	NULL
increased	NULL
following	NULL
TPA/PHA	NULL
stimulation	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
the	NULL
IL-9	NULL
mRNA	NULL
by	NULL
TPA/PHA	NULL
reached	NULL
the	NULL
maximum	NULL
level	NULL
11	NULL
h	NULL
after	NULL
stimulation	NULL
and	NULL
slowly	NULL
decreased	NULL
thereafter	NULL
.	NULL

24	NULL
h	NULL
after	NULL
stimulation	NULL
,	NULL
the	NULL
steady	NULL
state	NULL
level	NULL
of	NULL
IL-9	NULL
mRNA	NULL
was	NULL
still	NULL
about	NULL
3	NULL
times	NULL
higher	NULL
than	NULL
that	NULL
in	NULL
unstimulated	NULL
cells	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
control	NULL
mechanisms	NULL
of	NULL
IL-9	NULL
gene	NULL
expression	NULL
after	NULL
TPA/PHA	NULL
stimulation	NULL
,	NULL
nuclear	NULL
run-on	NULL
assays	NULL
were	NULL
performed	NULL
to	NULL
measure	NULL
the	NULL
transcription	NULL
rate	NULL
of	NULL
the	NULL
IL-9	NULL
gene	NULL
in	NULL
C5MJ2	NULL
cells	NULL
following	NULL
TPA/PHA	NULL
treatment	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
the	NULL
Northern	NULL
blot	NULL
analysis	NULL
,	NULL
the	NULL
rate	NULL
of	NULL
IL-9	NULL
gene	NULL
transcription	NULL
was	NULL
low	NULL
in	NULL
unstimulated	NULL
cells	NULL
.	NULL

The	NULL
transcription	NULL
rate	NULL
of	NULL
the	NULL
IL-9	NULL
gene	NULL
was	NULL
drastically	NULL
increased	NULL
(	NULL
7-fold	NULL
)	NULL
2	NULL
h	NULL
after	NULL
stimulation	NULL
,	NULL
reached	NULL
the	NULL
peak	NULL
(	NULL
10-fold	NULL
)	NULL
at	NULL
5	NULL
h	NULL
,	NULL
and	NULL
then	NULL
gradually	NULL
decreased	NULL
.	NULL

These	NULL
results	NULL
,	NULL
together	NULL
with	NULL
the	NULL
observation	NULL
that	NULL
the	NULL
steady-state	NULL
level	NULL
of	NULL
the	NULL
IL-9	NULL
mRNA	NULL
peaked	NULL
at	NULL
11	NULL
h	NULL
of	NULL
induction	NULL
(	NULL
15.5-fold	NULL
)	NULL
in	NULL
Northern	NULL
blot	NULL
analysis	NULL
,	NULL
suggest	NULL
that	NULL
different	NULL
mechanisms	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
accumulation	NULL
of	NULL
the	NULL
IL-9	NULL
message	NULL
.	NULL

The	NULL
mRNA	NULL
induction	NULL
observed	NULL
at	NULL
the	NULL
first	NULL
5	NULL
h	NULL
resulted	NULL
mainly	NULL
from	NULL
the	NULL
transcriptional	NULL
activation	NULL
since	NULL
both	NULL
Northern	NULL
blot	NULL
and	NULL
nuclear	NULL
run-on	NULL
analyses	NULL
showed	NULL
identical	NULL
induction	NULL
folds	NULL
of	NULL
the	NULL
IL-9	NULL
mRNA	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
a	NULL
predominantly	NULL
posttranscriptional	NULL
event	NULL
was	NULL
evidenced	NULL
at	NULL
11	NULL
h	NULL
of	NULL
activation	NULL
,	NULL
suggesting	NULL
a	NULL
shift	NULL
in	NULL
the	NULL
mechanisms	NULL
regulating	NULL
IL-9	NULL
mRNA	NULL
accumulation	NULL
from	NULL
the	NULL
transcriptional	NULL
to	NULL
the	NULL
posttranscription	NULL
level	NULL
,	NULL
most	NULL
likely	NULL
through	NULL
increasing	NULL
the	NULL
stability	NULL
of	NULL
the	NULL
message	NULL
.	NULL

Transcriptional	NULL
Regulation	NULL
of	NULL
IL-9	NULL
Gene	NULL
Expression	NULL
5'-Mapping	NULL
of	NULL
the	NULL
IL-9	NULL
mRNA-Transcription	NULL
initiation	NULL
site	NULL
for	NULL
the	NULL
IL-9	NULL
gene	NULL
in	NULL
C5MJ2	NULL
cells	NULL
was	NULL
determined	NULL
by	NULL
primer	NULL
extension	NULL
and	NULL
RNase	NULL
protection	NULL
methods	NULL
.	NULL

In	NULL
primer	NULL
extension	NULL
experiments	NULL
,	NULL
two	NULL
bands	NULL
with	NULL
different	NULL
densities	NULL
were	NULL
observed	NULL
by	NULL
using	NULL
total	NULL
RNA	NULL
from	NULL
activated	NULL
C5MJ2	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

The	NULL
major	NULL
band	NULL
(	NULL
82	NULL
%	NULL
)	NULL
was	NULL
80	NULL
bases	NULL
in	NULL
length	NULL
,	NULL
indicating	NULL
IL-9	NULL
gene	NULL
transcription	NULL
mainly	NULL
initiated	NULL
at	NULL
24	NULL
bases	NULL
upstream	NULL
from	NULL
the	NULL
translation	NULL
start	NULL
codon	NULL
ATG	NULL
and	NULL
25	NULL
bases	NULL
downstream	NULL
from	NULL
the	NULL
TATA	NULL
box	NULL
.	NULL

The	NULL
minor	NULL
band	NULL
(	NULL
18	NULL
%	NULL
)	NULL
,	NULL
3	NULL
bases	NULL
longer	NULL
than	NULL
the	NULL
main	NULL
band	NULL
,	NULL
was	NULL
probably	NULL
an	NULL
overextended	NULL
product	NULL
.	NULL

In	NULL
RNase	NULL
protection	NULL
assays	NULL
,	NULL
one	NULL
protected	NULL
band	NULL
was	NULL
obtained	NULL
with	NULL
total	NULL
RNA	NULL
from	NULL
both	NULL
unstimulated	NULL
and	NULL
stimulated	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
following	NULL
RNase	NULL
digestion	NULL
.	NULL

The	NULL
size	NULL
of	NULL
the	NULL
protected	NULL
fragment	NULL
corresponds	NULL
to	NULL
the	NULL
size	NULL
of	NULL
the	NULL
major	NULL
band	NULL
derived	NULL
from	NULL
the	NULL
primer	NULL
extension	NULL
experiment	NULL
,	NULL
suggesting	NULL
that	NULL
transcription	NULL
initiates	NULL
at	NULL
base	NULL
880	NULL
(	NULL
according	NULL
to	NULL
the	NULL
numbering	NULL
system	NULL
in	NULL
the	NULL
published	NULL
human	NULL
IL-9	NULL
genomic	NULL
sequence	NULL
;	NULL
Ref	NULL
.	NULL

18	NULL
)	NULL
.	NULL

This	NULL
base	NULL
is	NULL
therefore	NULL
considered	NULL
as	NULL
the	NULL
transcription	NULL
initiation	NULL
site	NULL
of	NULL
the	NULL
IL-9	NULL
gene	NULL
and	NULL
all	NULL
the	NULL
IL-9	NULL
sequences	NULL
in	NULL
this	NULL
paper	NULL
will	NULL
be	NULL
numbered	NULL
accordingly	NULL
.	NULL

Our	NULL
5'-mapping	NULL
results	NULL
were	NULL
slightly	NULL
different	NULL
from	NULL
the	NULL
ones	NULL
mapped	NULL
in	NULL
stimulated	NULL
PBMC	NULL
cells	NULL
(	NULL
3	NULL
)	NULL
,	NULL
which	NULL
probably	NULL
reflect	NULL
the	NULL
differences	NULL
in	NULL
the	NULL
control	NULL
mechanisms	NULL
of	NULL
IL-9	NULL
gene	NULL
expression	NULL
in	NULL
different	NULL
cell	NULL
lines	NULL
.	NULL

Positive	NULL
and	NULL
Negative	NULL
Regulatory	NULL
Regions	NULL
in	NULL
the	NULL
IL-9	NULL
Promot-er-We	NULL
have	NULL
demonstrated	NULL
previously	NULL
that	NULL
a	NULL
0.9-kilobase	NULL
5'-flanking	NULL
region	NULL
of	NULL
the	NULL
human	NULL
IL-9	NULL
gene	NULL
was	NULL
able	NULL
to	NULL
direct	NULL
the	NULL
reporter	NULL
gene	NULL
expression	NULL
in	NULL
response	NULL
to	NULL
TPA/PHA	NULL
stimulation	NULL
in	NULL
C5MJ2	NULL
cells	NULL
(	NULL
18	NULL
)	NULL
.	NULL

To	NULL
further	NULL
identify	NULL
regions	NULL
of	NULL
possible	NULL
functional	NULL
significance	NULL
within	NULL
this	NULL
0.9-kilobase	NULL
sequence	NULL
,	NULL
a	NULL
series	NULL
of	NULL
deletion	NULL
mutants	NULL
were	NULL
constructed	NULL
for	NULL
transient	NULL
expression	NULL
in	NULL
C5MJ2	NULL
cells	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
the	NULL
expression	NULL
level	NULL
of	NULL
the	NULL
luciferase	NULL
reporter	NULL
gene	NULL
was	NULL
steadily	NULL
increased	NULL
when	NULL
the	NULL
DNA	NULL
sequence	NULL
between	NULL
-878	NULL
and	NULL
-379	NULL
was	NULL
deleted	NULL
,	NULL
implying	NULL
the	NULL
existence	NULL
of	NULL
negative	NULL
control	NULL
elements	NULL
in	NULL
this	NULL
region	NULL
.	NULL

The	NULL
luciferase	NULL
activity	NULL
fluctuated	NULL
between	NULL
-379	NULL
and	NULL
-143	NULL
:	NULL
the	NULL
expression	NULL
level	NULL
reached	NULL
the	NULL
maximum	NULL
with	NULL
construct	NULL
pIL-9-D4	NULL
(	NULL
-379	NULL
)	NULL
and	NULL
decreased	NULL
about	NULL
2-fold	NULL
with	NULL
construct	NULL
pIL-9-D5	NULL
(	NULL
-299	NULL
)	NULL
;	NULL
After	NULL
deletion	NULL
of	NULL
another	NULL
86-base	NULL
pair	NULL
sequence	NULL
(	NULL
-213	NULL
,	NULL
pIL-9-D6	NULL
)	NULL
,	NULL
the	NULL
reporter	NULL
gene	NULL
expression	NULL
increased	NULL
again	NULL
,	NULL
especially	NULL
after	NULL
TPA/PHA	NULL
induction	NULL
;	NULL
When	NULL
an	NULL
additional	NULL
70-base	NULL
pair	NULL
sequence	NULL
was	NULL
deleted	NULL
(	NULL
-143	NULL
,	NULL
pIL-9-D7	NULL
)	NULL
,	NULL
the	NULL
luciferase	NULL
activity	NULL
decreased	NULL
5-6-fold	NULL
.	NULL

These	NULL
results	NULL
suggested	NULL
that	NULL
there	NULL
are	NULL
several	NULL
positive	NULL
and	NULL
negative	NULL
regulatory	NULL
elements	NULL
present	NULL
between	NULL
-379	NULL
and	NULL
-143	NULL
.	NULL

Through	NULL
computer	NULL
search	NULL
,	NULL
several	NULL
DNA	NULL
sequences	NULL
within	NULL
-379	NULL
to	NULL
-143	NULL
were	NULL
found	NULL
to	NULL
be	NULL
similar	NULL
to	NULL
the	NULL
binding	NULL
sites	NULL
of	NULL
certain	NULL
known	NULL
transcription	NULL
factors	NULL
.	NULL

These	NULL
sites	NULL
included	NULL
a	NULL
«	NULL
B-like	NULL
binding	NULL
motif	NULL
at	NULL
-331	NULL
to	NULL
-317	NULL
,	NULL
an	NULL
Spl-like	NULL
site	NULL
at	NULL
-317	NULL
to	NULL
-307	NULL
,	NULL
an	NULL
AP-3-like	NULL
site	NULL
at	NULL
-306	NULL
to	NULL
-298	NULL
,	NULL
and	NULL
an	NULL
AP-1-like	NULL
site	NULL
at	NULL
-146	NULL
to	NULL
-140	NULL
.	NULL

Except	NULL
the	NULL
AP-1-like	NULL
site	NULL
,	NULL
none	NULL
of	NULL
the	NULL
other	NULL
sites	NULL
were	NULL
demonstrated	NULL
to	NULL
be	NULL
important	NULL
in	NULL
controlling	NULL
IL-9	NULL
gene	NULL
transcription	NULL
by	NULL
mu-tagenesis	NULL
studies	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
AP-1-like	NULL
site	NULL
at	NULL
-146	NULL
to	NULL
-140	NULL
was	NULL
demonstrated	NULL
to	NULL
be	NULL
functional	NULL
in	NULL
IL-9	NULL
gene	NULL
expression	NULL
,	NULL
since	NULL
both	NULL
basal	NULL
and	NULL
TPA/PHA-inducible	NULL
luciferase	NULL
activities	NULL
decreased	NULL
about	NULL
2-3-fold	NULL
when	NULL
this	NULL
site	NULL
was	NULL
mutated	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

This	NULL
AP-1-like	NULL
site	NULL
differs	NULL
from	NULL
the	NULL
AP-1	NULL
consensus	NULL
sequence	NULL
by	NULL
only	NULL
one	NULL
nucleotide	NULL
.	NULL

The	NULL
nuclear	NULL
proteins	NULL
binding	NULL
to	NULL
this	NULL
site	NULL
were	NULL
found	NULL
to	NULL
be	NULL
inducible	NULL
by	NULL
TPA/PHA	NULL
stimulation	NULL
in	NULL
the	NULL
gel	NULL
shift	NULL
assay	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

Mutations	NULL
at	NULL
this	NULL
AP-1	NULL
site	NULL
abolished	NULL
formation	NULL
of	NULL
the	NULL
DNA-protein	NULL
complexes	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

These	NULL
DNA-binding	NULL
proteins	NULL
were	NULL
suggested	NULL
to	NULL
be	NULL
c-Jun	NULL
and	NULL
c-Fos	NULL
by	NULL
the	NULL
gel	NULL
supershift	NULL
assay	NULL
,	NULL
since	NULL
anti-c-Jun	NULL
antibody	NULL
supershifted	NULL
the	NULL
retarded	NULL
band	NULL
and	NULL
anti-c-Fos	NULL
antibody	NULL
inhibited	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
DNA-protein	NULL
complexes	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Transcriptional	NULL
Regulation	NULL
of	NULL
IL-9	NULL
Gene	NULL
Expression	NULL
350	NULL
D	NULL
unstimulated	NULL
300	NULL
|-	NULL
WJ	NULL
traphHa	NULL
ity	NULL
I	NULL
Relative	NULL
luciferase	NULL
activ	NULL
50	NULL
|	NULL
phIL-9-D8	NULL
-	NULL
phil-9-010	NULL
-	NULL
phil-9-012	NULL
.	NULL

phll-9-013	NULL
(	NULL
-106	NULL
)	NULL
(	NULL
-90	NULL
)	NULL
(	NULL
-80	NULL
)	NULL
(	NULL
-74	NULL
)	NULL
(	NULL
-63	NULL
)	NULL
W-	NULL
-80	NULL
5°	NULL
-CTTGGTATCAGTTTGATGTCAGGGTTTTTCCGT-3'-47	NULL
mi	NULL
3	NULL
!	NULL

M2	NULL
3+	NULL
M3	NULL
TAc	NULL
--	NULL
--	NULL
~~~~-	NULL
3+	NULL
ma	NULL
§ree	NULL
--	NULL
-~-	NULL
GCATAC-	NULL
-ATGA	NULL
--	NULL
--	NULL
TA	NULL
--	NULL
--	NULL
--	NULL
-~~~	NULL
3°	NULL
200	NULL
[	NULL
_	NULL
]	NULL
unstimulated	NULL
B	NULL
toawpra	NULL
tY	NULL
_	NULL
,	NULL
00	NULL
|	NULL
Relative	NULL
luciferase	NULL
activi	NULL
50	NULL
|	NULL
ll	NULL
phtL-9-D11	NULL
_	NULL
pIL-g-M1	NULL
_	NULL
phil-9-M2	NULL
-	NULL
phil-9-M3	NULL
_	NULL
phIL-9-M4	NULL
Fic	NULL
.	NULL

6	NULL
.	NULL

Transcriptional	NULL
activity	NULL
of	NULL
the	NULL
proximal	NULL
region	NULL
between	NULL
-80	NULL
and	NULL
-47	NULL
of	NULL
the	NULL
IL-9	NULL
gene	NULL
.	NULL

A	NULL
,	NULL
deletion	NULL
analysis	NULL
of	NULL
activation	NULL
region	NULL
.	NULL

Each	NULL
IL-9	NULL
luciferase	NULL
reporter	NULL
construct	NULL
was	NULL
transiently	NULL
transfected	NULL
into	NULL
C5MJ2	NULL
cells	NULL
,	NULL
and	NULL
transfected	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
or	NULL
without	NULL
TPA/PHA	NULL
stimulation	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

The	NULL
mean	NULL
values	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
are	NULL
shown	NULL
.	NULL

The	NULL
number	NULL
in	NULL
the	NULL
bracket	NULL
corresponds	NULL
to	NULL
the	NULL
position	NULL
in	NULL
the	NULL
15819	NULL
The	NULL
sequence	NULL
between	NULL
-125	NULL
and	NULL
-46	NULL
appeared	NULL
to	NULL
be	NULL
essential	NULL
for	NULL
the	NULL
constitutive	NULL
and	NULL
TPA/PHA-inducible	NULL
expression	NULL
of	NULL
the	NULL
IL-9	NULL
gene	NULL
in	NULL
C5MJ2	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

The	NULL
construct	NULL
pIL-9-D9	NULL
(	NULL
-46	NULL
)	NULL
showed	NULL
very	NULL
low	NULL
basal	NULL
level	NULL
reporter	NULL
gene	NULL
expression	NULL
and	NULL
failed	NULL
to	NULL
respond	NULL
to	NULL
TPA	NULL
induction	NULL
.	NULL

An	NULL
8-fold	NULL
(	NULL
uninduced	NULL
)	NULL
and	NULL
24-fold	NULL
(	NULL
TPA/PHA-induced	NULL
)	NULL
increase	NULL
in	NULL
promoter	NULL
activity	NULL
was	NULL
noted	NULL
when	NULL
-125	NULL
to	NULL
-47	NULL
sequence	NULL
was	NULL
added	NULL
.	NULL

To	NULL
localize	NULL
the	NULL
DNA	NULL
sequences	NULL
interacting	NULL
with	NULL
nuclear	NULL
proteins	NULL
,	NULL
DNase	NULL
I	NULL
footprinting	NULL
was	NULL
performed	NULL
using	NULL
a	NULL
5'-end-labeled	NULL
probe	NULL
covering	NULL
-125	NULL
to	NULL
+7	NULL
.	NULL

As	NULL
indicated	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
the	NULL
region	NULL
from	NULL
position	NULL
-45	NULL
to	NULL
-80	NULL
was	NULL
protected	NULL
from	NULL
DNase	NULL
I	NULL
digestion	NULL
,	NULL
suggesting	NULL
that	NULL
DNA-protein	NULL
interactions	NULL
exist	NULL
within	NULL
this	NULL
region	NULL
.	NULL

Minimum	NULL
Sequences	NULL
for	NULL
the	NULL
Basal	NULL
and	NULL
Induced	NULL
Expression	NULL
of	NULL
the	NULL
IL-9	NULL
Gene	NULL
in	NULL
C5MJ2	NULL
Cells-To	NULL
identify	NULL
the	NULL
minimum	NULL
sequence	NULL
that	NULL
mediates	NULL
the	NULL
basal	NULL
and	NULL
TPA-induced	NULL
expression	NULL
of	NULL
the	NULL
IL-9	NULL
gene	NULL
,	NULL
the	NULL
deletion	NULL
mutants	NULL
within	NULL
the	NULL
proximal	NULL
region	NULL
from	NULL
-90	NULL
to	NULL
-63	NULL
of	NULL
the	NULL
IL-9	NULL
promoter	NULL
were	NULL
constructed	NULL
.	NULL

They	NULL
were	NULL
designated	NULL
as	NULL
phIL-9-D10	NULL
to	NULL
phIL-9-D13	NULL
,	NULL
beginning	NULL
at	NULL
-90	NULL
,	NULL
-80	NULL
,	NULL
-74	NULL
,	NULL
and	NULL
-63	NULL
,	NULL
respectively	NULL
.	NULL

Transient	NULL
expression	NULL
of	NULL
these	NULL
constructs	NULL
in	NULL
C5MJ2	NULL
cells	NULL
showed	NULL
that	NULL
phIL-9-D10	NULL
and	NULL
phIL-9-D11	NULL
generated	NULL
luciferase	NULL
activities	NULL
comparable	NULL
to	NULL
phIL-9-D8	NULL
(	NULL
-125	NULL
)	NULL
,	NULL
but	NULL
a	NULL
5-10-fold	NULL
decrease	NULL
in	NULL
luciferase	NULL
activity	NULL
was	NULL
observed	NULL
in	NULL
transfections	NULL
with	NULL
constructs	NULL
phIL-9-D12	NULL
and	NULL
IL-9-D13	NULL
,	NULL
respectively	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
.	NULL

Since	NULL
phIL-9-D9	NULL
(	NULL
-47	NULL
)	NULL
had	NULL
very	NULL
low	NULL
level	NULL
of	NULL
luciferase	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
,	NULL
DNA	NULL
cis-elements	NULL
were	NULL
proposed	NULL
to	NULL
be	NULL
localized	NULL
in	NULL
the	NULL
region	NULL
between	NULL
-47	NULL
and	NULL
-80	NULL
.	NULL

This	NULL
result	NULL
is	NULL
consistent	NULL
with	NULL
that	NULL
of	NULL
the	NULL
DNase	NULL
I	NULL
footprinting	NULL
assay	NULL
.	NULL

A	NULL
closer	NULL
inspection	NULL
of	NULL
the	NULL
sequences	NULL
between	NULL
-47	NULL
and	NULL
-80	NULL
revealed	NULL
two	NULL
sites	NULL
highly	NULL
homologous	NULL
to	NULL
the	NULL
consensus	NULL
sequences	NULL
for	NULL
NF-kB	NULL
and	NULL
cAMP	NULL
response	NULL
element	NULL
(	NULL
CRE	NULL
)	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
B-like	NULL
binding	NULL
motif	NULL
(	NULL
GGGTTTTTCC	NULL
)	NULL
is	NULL
located	NULL
at	NULL
-59	NULL
to	NULL
-50	NULL
,	NULL
and	NULL
the	NULL
CRE-like	NULL
motif	NULL
(	NULL
TGATGTCA	NULL
)	NULL
is	NULL
immediately	NULL
upstream	NULL
from	NULL
this	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
.	NULL

To	NULL
investigate	NULL
whether	NULL
these	NULL
two	NULL
sites	NULL
and	NULL
their	NULL
neighboring	NULL
sequences	NULL
contribute	NULL
to	NULL
the	NULL
promoter	NULL
activity	NULL
,	NULL
mutations	NULL
were	NULL
introduced	NULL
into	NULL
these	NULL
two	NULL
potential	NULL
binding	NULL
sites	NULL
as	NULL
well	NULL
as	NULL
their	NULL
adjacent	NULL
upstream	NULL
sequences	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
any	NULL
mutation	NULL
within	NULL
the	NULL
NF-	NULL
«	NULL
B-like	NULL
binding	NULL
motif	NULL
(	NULL
phIL-9-M3	NULL
)	NULL
,	NULL
the	NULL
CRE-like	NULL
site	NULL
(	NULL
phIL-9-M2	NULL
)	NULL
or	NULL
its	NULL
adjacent	NULL
6-base	NULL
pair	NULL
upstream	NULL
sequence	NULL
(	NULL
phIL-9-M1	NULL
)	NULL
caused	NULL
a	NULL
90	NULL
%	NULL
decrease	NULL
in	NULL
the	NULL
basal	NULL
level	NULL
and	NULL
TPA/PHA-induced	NULL
expression	NULL
of	NULL
the	NULL
reporter	NULL
gene	NULL
.	NULL

Simultaneous	NULL
mutations	NULL
at	NULL
these	NULL
three	NULL
sites	NULL
(	NULL
phIL-9-M4	NULL
)	NULL
almost	NULL
completely	NULL
abolished	NULL
the	NULL
promoter	NULL
activity	NULL
.	NULL

These	NULL
results	NULL
indicated	NULL
that	NULL
the	NULL
three	NULL
different	NULL
sites	NULL
are	NULL
very	NULL
important	NULL
for	NULL
IL-9	NULL
gene	NULL
expression	NULL
and	NULL
they	NULL
are	NULL
likely	NULL
to	NULL
regulate	NULL
transcription	NULL
of	NULL
the	NULL
IL-9	NULL
gene	NULL
in	NULL
a	NULL
cooperative	NULL
manner	NULL
in	NULL
C5MJ2	NULL
cells	NULL
.	NULL

Interactions	NULL
of	NULL
Nuclear	NULL
Proteins	NULL
with	NULL
the	NULL
Proximal	NULL
Region	NULL
between	NULL
-47	NULL
and	NULL
-80	NULL
of	NULL
the	NULL
IL-9	NULL
Promoter-To	NULL
determine	NULL
whether	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
CREB	NULL
,	NULL
and	NULL
other	NULL
transcription	NULL
factors	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
binding	NULL
to	NULL
the	NULL
proximal	NULL
region	NULL
between	NULL
-47	NULL
and	NULL
-80	NULL
,	NULL
the	NULL
gel	NULL
shift	NULL
assays	NULL
were	NULL
performed	NULL
with	NULL
DNA	NULL
fragments	NULL
spanning	NULL
from	NULL
-47	NULL
to	NULL
-90	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7B	NULL
,	NULL
nuclear	NULL
extracts	NULL
from	NULL
both	NULL
unstimulated	NULL
and	NULL
stimulated	NULL
cells	NULL
formed	NULL
DNA-protein	NULL
complexes	NULL
with	NULL
this	NULL
sequence	NULL
.	NULL

It	NULL
was	NULL
noticed	NULL
that	NULL
TPA/PHA	NULL
stimulation	NULL
increased	NULL
the	NULL
intensity	NULL
of	NULL
the	NULL
major	NULL
DNA-protein	NULL
complexes	NULL
.	NULL

To	NULL
identify	NULL
individual	NULL
binding	NULL
sites	NULL
,	NULL
competition	NULL
experiments	NULL
were	NULL
carried	NULL
out	NULL
with	NULL
DNA	NULL
fragments	NULL
bearing	NULL
different	NULL
binding	NULL
motifs	NULL
of	NULL
several	NULL
transcrip-	NULL
IL-9	NULL
5'-flanking	NULL
region	NULL
at	NULL
which	NULL
each	NULL
clone	NULL
was	NULL
truncated	NULL
.	NULL

B	NULL
,	NULL
substitution	NULL
mutation	NULL
analysis	NULL
within	NULL
the	NULL
proximal	NULL
region	NULL
between	NULL
-80	NULL
and	NULL
-47	NULL
.	NULL

Substitution	NULL
mutants	NULL
were	NULL
constructed	NULL
by	NULL
inserting	NULL
the	NULL
PCR	NULL
fragments	NULL
between	NULL
-80	NULL
and	NULL
+8	NULL
into	NULL
pXP2	NULL
vectors	NULL
.	NULL

The	NULL
sequences	NULL
of	NULL
wild	NULL
type	NULL
and	NULL
mutation	NULL
within	NULL
-80	NULL
and	NULL
-47	NULL
in	NULL
each	NULL
construct	NULL
are	NULL
shown	NULL
(	NULL
dashes	NULL
,	NULL
unchanged	NULL
bases	NULL
;	NULL
underline	NULL
,	NULL
NF-	NULL
«	NULL
B-like	NULL
motif	NULL
)	NULL
.	NULL

Luciferase	NULL
activities	NULL
of	NULL
C5MJ2	NULL
cells	NULL
transfected	NULL
with	NULL
various	NULL
mutant	NULL
plasmids	NULL
are	NULL
shown	NULL
as	NULL
mean	NULL
values	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
15820	NULL
Transcriptional	NULL
Regulation	NULL
of	NULL
IL-9	NULL
Gene	NULL
Expression	NULL
A	NULL
B	NULL
8	NULL
-a	NULL
R	NULL
E	NULL
mnp	NULL
pe	NULL
Comp	NULL
.	NULL

-	NULL
-	NULL
&	NULL
&	NULL
<	NULL
4	NULL
&	NULL
B	NULL
UNE	NULL
=	NULL
4	NULL
-	NULL
-	NULL
-	NULL
-	NULL
-	NULL
sNB	NULL
-	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
PWL	NULL
-90	NULL
5	NULL
!	NULL

PW2	NULL
-80	NULL
-	NULL
5	NULL
-CTTGGTATCAGTTTGATGTCAGGGTTTTTCCGT-3	NULL
!	NULL

-47	NULL
PMi	NULL
-80	NULL
5'-CTTGCTGCATACTTGATGACAGGGTTTTTCCGT-3'-47	NULL
PM2	NULL
-80	NULL
5'-CTTGGTATCAGTTTATGATCAGGGTTTTTCCGT-3'-47	NULL
PM3	NULL
-	NULL
-80	NULL
|	NULL
5	NULL
-	NULL
>	NULL
“	NULL
“	NULL
u	NULL
PM4	NULL
-80	NULL
5'-CTTGCTGCATACTTATGATCAGTATITTTCCGT-3'-47	NULL
C	NULL
D	NULL
Pre	NULL
IgG	NULL
400-0	NULL
o-	NULL
#	NULL
008	NULL
0s	NULL
-	NULL
o-	NULL
+0	NULL
-	NULL
W	NULL
Probe	NULL
-84	NULL
5'-GGCTCTTGGTATCAGTTTGATCTCAGG-3	NULL
'	NULL
-58	NULL
Anti-c-Jun	NULL
-o	NULL
#	NULL
-	NULL
s	NULL
-	NULL
=	NULL
+	NULL
=	NULL
_	NULL
>	NULL
Anti-c-Fos	NULL
=o	NULL
=o	NULL
+	NULL
#	NULL
to	NULL
mo	NULL
mo	NULL
t	NULL
oof	NULL
=o	NULL
=	NULL
M	NULL
Probe	NULL
-84	NULL
5'-GGCTCTTGGTG	NULL
@	NULL
CATACTTATGATCAGG-3	NULL
'	NULL
-58	NULL
Anti-NF-kB/Rel	NULL
-	NULL
-	NULL
-	NULL
to	NULL
&	NULL
40	NULL
-	NULL
o-	NULL
-o	NULL
Anti-NF-kB/p51	NULL
-	NULL
-	NULL
-	NULL
so	NULL
-	NULL
-	NULL
4	NULL
+	NULL
ee	NULL
Anti-	NULL
CREB	NULL
mom	NULL
+	NULL
to	NULL
=o	NULL
=o	NULL
=	NULL
of	NULL
-o	NULL
+	NULL
uNE	NULL
$	NULL
008	NULL
00	NULL
>	NULL
o-	NULL
o-NF-kB/Rel	NULL
sos	NULL
%	NULL
i	NULL
Aine	NULL
ilk	NULL
sNE	NULL
-o	NULL
£	NULL
0+	NULL
0+	NULL
%	NULL
NF-kB/p51	NULL
Se	NULL
.	NULL

=o	NULL
k	NULL
00	NULL
>	NULL
os	NULL
O+	NULL
nos	NULL
W	NULL
probe	NULL
+o	NULL
#	NULL
0	NULL
-	NULL
4	NULL
+	NULL
1	NULL
2	NULL
3	NULL
40	NULL
50	NULL
60	NULL
7	NULL
B	NULL
9	NULL
10	NULL
M	NULL
probe	NULL
-o	NULL
-	NULL
#	NULL
o-	NULL
o-on	NULL
as	NULL
Anti-c-Jun	NULL
-	NULL
-	NULL
-	NULL
+0	NULL
«	NULL
=	NULL
®	NULL
w-	NULL
®	NULL
Pre	NULL
IgG	NULL
-o	NULL
-	NULL
-	NULL
1	NULL
3	NULL
4	NULL
KD	NULL
b*	NULL
|	NULL
|	NULL
v	NULL
u	NULL
w	NULL
-106	NULL
-80	NULL
-49.5	NULL
l	NULL
‘	NULL
h	NULL
in	NULL
-32.5	NULL
E	NULL
NHNEQ	NULL
‘	NULL
EEE	NULL
EER	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
Fic	NULL
.	NULL

7	NULL
.	NULL

Characterization	NULL
of	NULL
trans-acting	NULL
proteins	NULL
binding	NULL
to	NULL
the	NULL
sequence	NULL
between	NULL
-80	NULL
and	NULL
-47	NULL
of	NULL
the	NULL
5	NULL
'	NULL
-flanking	NULL
region	NULL
of	NULL
the	NULL
IL-9	NULL
gene	NULL
.	NULL

A	NULL
,	NULL
the	NULL
sequences	NULL
of	NULL
upper	NULL
strand	NULL
of	NULL
duplex	NULL
oligonucleotides	NULL
used	NULL
in	NULL
the	NULL
gel	NULL
shift	NULL
or	NULL
supershift	NULL
assay	NULL
.	NULL

The	NULL
mutated	NULL
nucleotides	NULL
are	NULL
underlined	NULL
.	NULL

610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Transcriptional	NULL
Regulation	NULL
of	NULL
IL-9	NULL
Gene	NULL
Expression	NULL
tion	NULL
factors	NULL
.	NULL

Our	NULL
data	NULL
showed	NULL
that	NULL
proteins	NULL
binding	NULL
to	NULL
this	NULL
sequence	NULL
are	NULL
specific	NULL
and	NULL
the	NULL
binding	NULL
could	NULL
be	NULL
competed	NULL
by	NULL
unlabeled	NULL
DNA	NULL
fragment	NULL
containing	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
NF-	NULL
«	NULL
B	NULL
motif	NULL
,	NULL
but	NULL
not	NULL
by	NULL
unlabeled	NULL
DNA	NULL
fragments	NULL
containing	NULL
the	NULL
binding	NULL
motifs	NULL
for	NULL
NF-AT	NULL
p/c	NULL
,	NULL
AP-1	NULL
,	NULL
and	NULL
CREB	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
.	NULL

To	NULL
further	NULL
characterize	NULL
proteins	NULL
binding	NULL
to	NULL
this	NULL
region	NULL
,	NULL
gel	NULL
supershift	NULL
assays	NULL
were	NULL
performed	NULL
using	NULL
specific	NULL
antibodies	NULL
against	NULL
NF-kB	NULL
,	NULL
CREB	NULL
,	NULL
c-Jun	NULL
,	NULL
and	NULL
c-Fos	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7C	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
was	NULL
demonstrated	NULL
to	NULL
be	NULL
one	NULL
of	NULL
the	NULL
components	NULL
in	NULL
the	NULL
DNA-protein	NULL
complexes	NULL
since	NULL
antibodies	NULL
raised	NULL
against	NULL
both	NULL
Rel	NULL
and	NULL
p50	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
could	NULL
supershift	NULL
the	NULL
complexes	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
7	NULL
)	NULL
and	NULL
the	NULL
supershift	NULL
pattern	NULL
could	NULL
be	NULL
reversed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
excess	NULL
amount	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
peptides	NULL
(	NULL
lanes	NULL
6	NULL
and	NULL
8	NULL
)	NULL
.	NULL

The	NULL
anti-c-Jun	NULL
antibody	NULL
was	NULL
also	NULL
shown	NULL
to	NULL
be	NULL
able	NULL
to	NULL
shift	NULL
the	NULL
DNA-protein	NULL
complexes	NULL
in	NULL
the	NULL
supershift	NULL
assay	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
but	NULL
anti-c-Fos	NULL
and	NULL
anti-CREB	NULL
antibodies	NULL
failed	NULL
to	NULL
shift	NULL
the	NULL
retarded	NULL
band	NULL
.	NULL

The	NULL
CRE-like	NULL
motif	NULL
5TGATGTCA	NULL
3	NULL
'	NULL
at	NULL
-67	NULL
to	NULL
-60	NULL
differs	NULL
from	NULL
CRE	NULL
consensus	NULL
sequence	NULL
5'TGACGTCA	NULL
3	NULL
'	NULL
by	NULL
a	NULL
single	NULL
base	NULL
substitution	NULL
.	NULL

This	NULL
variant	NULL
CRE	NULL
sequence	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
have	NULL
a	NULL
markedly	NULL
reduced	NULL
binding	NULL
affinity	NULL
for	NULL
CREB	NULL
(	NULL
32	NULL
)	NULL
.	NULL

Our	NULL
gel	NULL
supershift	NULL
assays	NULL
and	NULL
competition	NULL
experiments	NULL
also	NULL
suggested	NULL
that	NULL
CRE	NULL
and	NULL
CREB	NULL
may	NULL
not	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
IL-9	NULL
expression	NULL
.	NULL

To	NULL
characterize	NULL
proteins	NULL
binding	NULL
to	NULL
the	NULL
upstream	NULL
region	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
,	NULL
the	NULL
UV-cross-linking	NULL
assay	NULL
was	NULL
performed	NULL
to	NULL
identify	NULL
proteins	NULL
binding	NULL
to	NULL
the	NULL
sequence	NULL
between	NULL
-77	NULL
and	NULL
-58	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7D	NULL
,	NULL
several	NULL
proteins	NULL
(	NULL
around	NULL
92	NULL
,	NULL
40	NULL
,	NULL
and	NULL
35	NULL
kDa	NULL
)	NULL
from	NULL
nuclear	NULL
extract	NULL
of	NULL
stimulated	NULL
cells	NULL
were	NULL
cross-linked	NULL
to	NULL
the	NULL
DNA	NULL
probe	NULL
(	NULL
Zane	NULL
2	NULL
)	NULL
.	NULL

UV	NULL
-cross-linking	NULL
performed	NULL
with	NULL
oligonucleotides	NULL
mutated	NULL
at	NULL
two	NULL
sites	NULL
demonstrated	NULL
to	NULL
be	NULL
important	NULL
by	NULL
functional	NULL
studies	NULL
resulted	NULL
in	NULL
the	NULL
disappearance	NULL
or	NULL
decrease	NULL
in	NULL
intensity	NULL
of	NULL
proteins	NULL
around	NULL
40	NULL
and	NULL
35	NULL
kDa	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
proteins	NULL
of	NULL
40	NULL
and	NULL
35	NULL
kDa	NULL
are	NULL
specific	NULL
DNA-binding	NULL
proteins	NULL
(	NULL
Zane	NULL
3	NULL
)	NULL
.	NULL

The	NULL
40-kDa	NULL
protein	NULL
was	NULL
inducible	NULL
and	NULL
was	NULL
demonstrated	NULL
to	NULL
be	NULL
c-Jun	NULL
by	NULL
immunoprecipitation	NULL
of	NULL
the	NULL
UV-cross-linked	NULL
proteins	NULL
with	NULL
anti-c-Jun	NULL
antibody	NULL
(	NULL
Zane	NULL
4	NULL
)	NULL
.	NULL

To	NULL
further	NULL
investigate	NULL
whether	NULL
proteins	NULL
binding	NULL
to	NULL
the	NULL
proximal	NULL
region	NULL
correlates	NULL
with	NULL
regulation	NULL
of	NULL
the	NULL
IL-9	NULL
gene	NULL
expression	NULL
,	NULL
we	NULL
used	NULL
oligonucleotides	NULL
with	NULL
mutations	NULL
within	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
its	NULL
adjacent	NULL
upstream	NULL
region	NULL
as	NULL
the	NULL
probes	NULL
in	NULL
the	NULL
gel	NULL
shift	NULL
assay	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
A	NULL
and	NULL
E	NULL
)	NULL
.	NULL

As	NULL
compared	NULL
with	NULL
wild	NULL
type	NULL
sequence	NULL
,	NULL
mutations	NULL
within	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
motif	NULL
or	NULL
its	NULL
adjacent	NULL
20-base	NULL
pair	NULL
upstream	NULL
sequence	NULL
hindered	NULL
the	NULL
DNA-protein	NULL
complexes	NULL
formation	NULL
(	NULL
Fig	NULL
.	NULL

7E	NULL
,	NULL
lanes	NULL
2-4	NULL
)	NULL
.	NULL

Simultaneous	NULL
mutations	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
its	NULL
adjacent	NULL
20-base	NULL
pair	NULL
upstream	NULL
sequence	NULL
completely	NULL
abolished	NULL
the	NULL
formation	NULL
of	NULL
DNA-protein	NULL
complexes	NULL
(	NULL
Zane	NULL
5	NULL
)	NULL
.	NULL

These	NULL
results	NULL
correlated	NULL
well	NULL
with	NULL
the	NULL
functional	NULL
study	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
,	NULL
in	NULL
which	NULL
IL-9	NULL
promoter	NULL
constructs	NULL
containing	NULL
the	NULL
same	NULL
mutations	NULL
generated	NULL
much	NULL
lower	NULL
luciferase	NULL
activities	NULL
as	NULL
compared	NULL
to	NULL
the	NULL
wild	NULL
type	NULL
construct	NULL
,	NULL
demonstrating	NULL
that	NULL
synergistic	NULL
binding	NULL
of	NULL
these	NULL
different	NULL
transcription	NULL
factors	NULL
to	NULL
the	NULL
same	NULL
promoter	NULL
region	NULL
is	NULL
crucial	NULL
for	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
IL-9	NULL
gene	NULL
in	NULL
C5MJ2	NULL
cells	NULL
.	NULL

DISCUSSION	NULL
In	NULL
this	NULL
study	NULL
,	NULL
the	NULL
up-regulation	NULL
of	NULL
IL-9	NULL
gene	NULL
expression	NULL
in	NULL
C5MJ2	NULL
cells	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
regulated	NULL
,	NULL
at	NULL
least	NULL
in	NULL
part	NULL
,	NULL
by	NULL
15821	NULL
transcriptional	NULL
activation	NULL
.	NULL

Functional	NULL
analysis	NULL
of	NULL
the	NULL
5'-flanking	NULL
sequence	NULL
of	NULL
the	NULL
IL-9	NULL
gene	NULL
revealed	NULL
several	NULL
positive	NULL
and	NULL
negative	NULL
regions	NULL
controlling	NULL
IL-9	NULL
gene	NULL
expression	NULL
.	NULL

One	NULL
positive	NULL
region	NULL
includes	NULL
an	NULL
AP-1	NULL
site	NULL
at	NULL
-146	NULL
to	NULL
-140	NULL
,	NULL
which	NULL
was	NULL
demonstrated	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
IL-9	NULL
gene	NULL
in	NULL
C5MJ2	NULL
cells	NULL
.	NULL

Members	NULL
of	NULL
the	NULL
AP-1	NULL
protein	NULL
family	NULL
have	NULL
been	NULL
reported	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
IL-2	NULL
,	NULL
IL-3	NULL
,	NULL
IL-4	NULL
,	NULL
IL-5	NULL
,	NULL
and	NULL
GM-CSF	NULL
in	NULL
T	NULL
cells	NULL
by	NULL
working	NULL
independently	NULL
or	NULL
cooperatively	NULL
with	NULL
other	NULL
transcription	NULL
factors	NULL
,	NULL
such	NULL
as	NULL
NF-AT	NULL
and	NULL
Oct1	NULL
(	NULL
33-37	NULL
)	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
AP-1	NULL
protein	NULL
was	NULL
found	NULL
not	NULL
only	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
AP-1	NULL
site	NULL
at	NULL
-146	NULL
to	NULL
-140	NULL
,	NULL
but	NULL
also	NULL
to	NULL
participate	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
DNA-protein	NULL
complexes	NULL
binding	NULL
to	NULL
another	NULL
important	NULL
proximal	NULL
region	NULL
(	NULL
-80	NULL
to	NULL
-47	NULL
)	NULL
of	NULL
the	NULL
IL-9	NULL
promoter	NULL
.	NULL

Therefore	NULL
,	NULL
AP-1	NULL
appears	NULL
to	NULL
be	NULL
an	NULL
important	NULL
general	NULL
transcription	NULL
factor	NULL
involved	NULL
in	NULL
the	NULL
up-regulation	NULL
of	NULL
a	NULL
large	NULL
number	NULL
of	NULL
cytokines	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
second	NULL
positive	NULL
regulatory	NULL
region	NULL
resides	NULL
within	NULL
positions	NULL
-80	NULL
to	NULL
-47	NULL
of	NULL
the	NULL
IL-9	NULL
promoter	NULL
.	NULL

Our	NULL
study	NULL
revealed	NULL
that	NULL
this	NULL
region	NULL
is	NULL
absolutely	NULL
required	NULL
for	NULL
IL-9	NULL
gene	NULL
expression	NULL
.	NULL

The	NULL
DNA	NULL
sequence	NULL
within	NULL
this	NULL
proximal	NULL
region	NULL
is	NULL
highly	NULL
conserved	NULL
in	NULL
evolution	NULL
(	NULL
identical	NULL
between	NULL
human	NULL
and	NULL
mouse	NULL
IL-9	NULL
promot-ers	NULL
)	NULL
.	NULL

Within	NULL
this	NULL
region	NULL
,	NULL
an	NULL
NF-	NULL
«	NULL
B	NULL
motif	NULL
at	NULL
-59	NULL
to	NULL
-50	NULL
as	NULL
well	NULL
as	NULL
its	NULL
20-base	NULL
pair	NULL
adjacent	NULL
upstream	NULL
sequence	NULL
were	NULL
demonstrated	NULL
to	NULL
be	NULL
critical	NULL
since	NULL
mutations	NULL
at	NULL
one	NULL
or	NULL
both	NULL
sites	NULL
drastically	NULL
decreased	NULL
the	NULL
promoter	NULL
activity	NULL
.	NULL

The	NULL
direct	NULL
interaction	NULL
of	NULL
NF-kB	NULL
with	NULL
this	NULL
region	NULL
was	NULL
also	NULL
confirmed	NULL
by	NULL
competition	NULL
experiments	NULL
and	NULL
the	NULL
gel	NULL
supershift	NULL
assay	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
or	NULL
related	NULL
proteins	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
play	NULL
important	NULL
roles	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
several	NULL
cytokines	NULL
(	NULL
37-41	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
is	NULL
required	NULL
for	NULL
the	NULL
activation	NULL
of	NULL
GM-CSF	NULL
gene	NULL
by	NULL
various	NULL
mitogens	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
37	NULL
,	NULL
41	NULL
)	NULL
.	NULL

Unlike	NULL
GM-CSF	NULL
gene	NULL
,	NULL
the	NULL
position	NULL
of	NULL
this	NULL
NF-	NULL
«	NULL
B	NULL
motif	NULL
in	NULL
IL-9	NULL
promoter	NULL
is	NULL
located	NULL
much	NULL
closer	NULL
to	NULL
the	NULL
TATA	NULL
box	NULL
.	NULL

Compared	NULL
with	NULL
this	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
in	NULL
the	NULL
IL-9	NULL
promoter	NULL
,	NULL
a	NULL
stretch	NULL
of	NULL
DNA	NULL
sequence	NULL
referred	NULL
to	NULL
as	NULL
the	NULL
conserved	NULL
lymphokin	NULL
element	NULL
0	NULL
(	NULL
CLEO	NULL
)	NULL
was	NULL
found	NULL
in	NULL
the	NULL
promoter	NULL
regions	NULL
of	NULL
the	NULL
GM-CSF	NULL
,	NULL
IL-4	NULL
,	NULL
and	NULL
IL-5	NULL
genes	NULL
(	NULL
22	NULL
)	NULL
.	NULL

CLEO	NULL
,	NULL
regarded	NULL
as	NULL
an	NULL
essential	NULL
cis-element	NULL
,	NULL
is	NULL
required	NULL
for	NULL
the	NULL
expression	NULL
of	NULL
GM-CSF	NULL
,	NULL
IL-4	NULL
,	NULL
and	NULL
IL-5	NULL
genes	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
and	NULL
contains	NULL
composite	NULL
binding	NULL
site	NULL
for	NULL
AP-1/Ets	NULL
or	NULL
NF-AT	NULL
factors	NULL
(	NULL
22	NULL
,	NULL
31	NULL
,	NULL
37	NULL
,	NULL
42-43	NULL
)	NULL
.	NULL

The	NULL
binding	NULL
sequences	NULL
for	NULL
NF-kB	NULL
,	NULL
Ets	NULL
and	NULL
NF-AT	NULL
proteins	NULL
are	NULL
quite	NULL
similar	NULL
,	NULL
all	NULL
of	NULL
which	NULL
have	NULL
the	NULL
AAAGG	NULL
motif	NULL
.	NULL

The	NULL
similarity	NULL
suggests	NULL
that	NULL
promoters	NULL
of	NULL
those	NULL
cytokines	NULL
on	NULL
chromosome	NULL
5	NULL
may	NULL
be	NULL
evolutionarily	NULL
related	NULL
and	NULL
also	NULL
raises	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
T	NULL
cell-restricted	NULL
expression	NULL
of	NULL
IL-9	NULL
may	NULL
be	NULL
attributed	NULL
to	NULL
the	NULL
unique	NULL
feature	NULL
of	NULL
its	NULL
promoter	NULL
sequence	NULL
.	NULL

It	NULL
should	NULL
be	NULL
pointed	NULL
out	NULL
that	NULL
in	NULL
addition	NULL
to	NULL
NF-kB	NULL
binding	NULL
to	NULL
the	NULL
proximal	NULL
region	NULL
between	NULL
-80	NULL
and	NULL
-47	NULL
,	NULL
c-Jun	NULL
and	NULL
the	NULL
proteins	NULL
of	NULL
35	NULL
kDa	NULL
have	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
specifically	NULL
bind	NULL
to	NULL
this	NULL
functional	NULL
region	NULL
.	NULL

c-Jun	NULL
may	NULL
bind	NULL
to	NULL
the	NULL
CRE-like	NULL
site	NULL
at	NULL
-67	NULL
to	NULL
-60	NULL
,	NULL
since	NULL
probes	NULL
with	NULL
mutations	NULL
within	NULL
this	NULL
CRE-like	NULL
motif	NULL
failed	NULL
to	NULL
give	NULL
rise	NULL
to	NULL
the	NULL
supershifted	NULL
band	NULL
using	NULL
anti-c-Jun	NULL
in	NULL
our	NULL
gel	NULL
supershift	NULL
assay	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
nature	NULL
of	NULL
35-kDa	NULL
proteins	NULL
remains	NULL
unclear	NULL
.	NULL

It	NULL
was	NULL
noticed	NULL
that	NULL
a	NULL
GATA	NULL
binding	NULL
motif	NULL
5'-TGATAC-3	NULL
'	NULL
exists	NULL
at	NULL
position	NULL
-76	NULL
to	NULL
-71	NULL
on	NULL
the	NULL
minus	NULL
strand	NULL
of	NULL
the	NULL
IL-9	NULL
promoter	NULL
,	NULL
and	NULL
mutations	NULL
containing	NULL
this	NULL
GATA	NULL
binding	NULL
site	NULL
(	NULL
pIL-9-M1	NULL
)	NULL
reduced	NULL
reporter	NULL
gene	NULL
expression	NULL
.	NULL

At	NULL
present	NULL
,	NULL
four	NULL
members	NULL
of	NULL
GATA	NULL
family	NULL
tran	NULL
B	NULL
,	NULL
gel	NULL
shift	NULL
assay	NULL
with	NULL
oligonucleotide	NULL
competitors	NULL
.	NULL

50-fold	NULL
molar	NULL
excess	NULL
of	NULL
competitors	NULL
were	NULL
preincubated	NULL
with	NULL
nuclear	NULL
proteins	NULL
for	NULL
5	NULL
min	NULL
before	NULL
addition	NULL
of	NULL
labeled	NULL
wild	NULL
type	NULL
probe	NULL
(	NULL
PW1	NULL
)	NULL
.	NULL

The	NULL
position	NULL
of	NULL
the	NULL
specific	NULL
binding	NULL
complex	NULL
is	NULL
indicated	NULL
by	NULL
an	NULL
arrow	NULL
.	NULL

C	NULL
,	NULL
gel	NULL
supershift	NULL
assay	NULL
with	NULL
antibodies	NULL
and	NULL
peptide	NULL
competitors	NULL
.	NULL

For	NULL
the	NULL
gel	NULL
supershift	NULL
assay	NULL
,	NULL
empirically	NULL
determined	NULL
amount	NULL
of	NULL
Abs	NULL
and	NULL
same	NULL
amount	NULL
of	NULL
preimmune	NULL
serum	NULL
were	NULL
preincubated	NULL
with	NULL
the	NULL
nuclear	NULL
proteins	NULL
before	NULL
adding	NULL
probes	NULL
(	NULL
PW1	NULL
)	NULL
.	NULL

In	NULL
the	NULL
corresponding	NULL
peptide	NULL
competition	NULL
assay	NULL
,	NULL
2	NULL
ug	NULL
of	NULL
the	NULL
specific	NULL
peptide	NULL
was	NULL
preincubated	NULL
with	NULL
Abs	NULL
before	NULL
binding	NULL
reactions	NULL
.	NULL

D	NULL
,	NULL
UV-cross-linking	NULL
studies	NULL
.	NULL

The	NULL
sequences	NULL
of	NULL
upper	NULL
strand	NULL
of	NULL
wild	NULL
type	NULL
and	NULL
mutation	NULL
probes	NULL
used	NULL
in	NULL
UV-cross-linking	NULL
study	NULL
are	NULL
shown	NULL
with	NULL
mutated	NULL
nucleotides	NULL
highlighted	NULL
.	NULL

After	NULL
UV	NULL
irradiation	NULL
of	NULL
the	NULL
DNA-protein	NULL
complexes	NULL
,	NULL
equal	NULL
volumes	NULL
of	NULL
the	NULL
same	NULL
sample	NULL
were	NULL
treated	NULL
either	NULL
with	NULL
anti-c-Jun	NULL
or	NULL
preimmune	NULL
IgG	NULL
,	NULL
followed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
anti-rabbit-IgG	NULL
agarose	NULL
.	NULL

The	NULL
UV-cross-linked	NULL
proteins	NULL
and	NULL
immunoprecipitates	NULL
were	NULL
fractionated	NULL
on	NULL
a	NULL
7.5	NULL
%	NULL
SDS-polyacrylamide	NULL
gel	NULL
.	NULL

E	NULL
,	NULL
gel	NULL
shift	NULL
assay	NULL
with	NULL
DNA	NULL
fragments	NULL
containing	NULL
substitution	NULL
mutations	NULL
.	NULL

The	NULL
position	NULL
of	NULL
the	NULL
specific	NULL
binding	NULL
complexes	NULL
is	NULL
marked	NULL
by	NULL
an	NULL
arrow	NULL
.	NULL

610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
15822	NULL
scription	NULL
factors	NULL
have	NULL
been	NULL
characterized	NULL
(	NULL
44-45	NULL
)	NULL
.	NULL

Among	NULL
them	NULL
,	NULL
only	NULL
GATA-3	NULL
is	NULL
predominantly	NULL
present	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
several	NULL
T	NULL
cell-specific	NULL
genes	NULL
(	NULL
46-48	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
IL-5	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
activated	NULL
by	NULL
GATA-3	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
43	NULL
)	NULL
.	NULL

Since	NULL
the	NULL
molecular	NULL
masses	NULL
of	NULL
GATA-3	NULL
proteins	NULL
are	NULL
around	NULL
45	NULL
kDa	NULL
,	NULL
it	NULL
is	NULL
unlikely	NULL
that	NULL
the	NULL
35-kDa	NULL
UV-cross-linked	NULL
proteins	NULL
are	NULL
GATA-3	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
our	NULL
results	NULL
suggest	NULL
that	NULL
synergistic	NULL
interactions	NULL
of	NULL
known	NULL
and	NULL
unknown	NULL
transcription	NULL
factors	NULL
are	NULL
likely	NULL
to	NULL
play	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
IL-9	NULL
expression	NULL
.	NULL

As	NULL
indicated	NULL
by	NULL
our	NULL
study	NULL
,	NULL
several	NULL
proteins	NULL
can	NULL
bind	NULL
to	NULL
the	NULL
proximal	NULL
region	NULL
between	NULL
-80	NULL
and	NULL
-47	NULL
.	NULL

Mutations	NULL
at	NULL
different	NULL
sites	NULL
within	NULL
this	NULL
region	NULL
not	NULL
only	NULL
decreased	NULL
reporter	NULL
gene	NULL
expression	NULL
but	NULL
also	NULL
abolished	NULL
the	NULL
formation	NULL
of	NULL
specific	NULL
DNA-protein	NULL
complexes	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
this	NULL
important	NULL
proximal	NULL
region	NULL
,	NULL
we	NULL
have	NULL
also	NULL
demonstrated	NULL
that	NULL
the	NULL
AP-1	NULL
site	NULL
at	NULL
-146	NULL
to	NULL
-140	NULL
can	NULL
be	NULL
regulated	NULL
by	NULL
AP-1	NULL
proteins	NULL
to	NULL
enhance	NULL
IL-9	NULL
promoter	NULL
activity	NULL
,	NULL
implying	NULL
``	NULL
cross-talk	NULL
``	NULL
and	NULL
cooperation	NULL
may	NULL
exist	NULL
between	NULL
these	NULL
two	NULL
regions	NULL
and	NULL
among	NULL
the	NULL
different	NULL
transcription	NULL
factors	NULL
.	NULL

The	NULL
cooperation	NULL
of	NULL
multiple	NULL
transcription	NULL
factors	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
IL-3	NULL
,	NULL
IL-5	NULL
,	NULL
and	NULL
GM-CSF	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
37	NULL
,	NULL
49	NULL
)	NULL
.	NULL

For	NULL
IL-9	NULL
gene	NULL
expression	NULL
,	NULL
its	NULL
T	NULL
cell-restricted	NULL
expression	NULL
pattern	NULL
may	NULL
be	NULL
mediated	NULL
by	NULL
certain	NULL
unknown	NULL
T	NULL
cell-specific	NULL
transcription	NULL
factors	NULL
and/or	NULL
by	NULL
a	NULL
unique	NULL
profile	NULL
of	NULL
combinatorial	NULL
interactions	NULL
of	NULL
common	NULL
transcription	NULL
factors	NULL
.	NULL

Acknowledgment-	NULL
We	NULL
thank	NULL
Dr.	NULL
Chou-Zen	NULL
Giam	NULL
at	NULL
Case	NULL
Western	NULL
Reserve	NULL
University	NULL
for	NULL
providing	NULL
anti-CREB	NULL
and	NULL
CRE	NULL
nucleotide	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Renauld	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Houssiau	NULL
,	NULL
F.	NULL
,	NULL
Louahed	NULL
,	NULL
J.	NULL
,	NULL
Vink	NULL
,	NULL
A.	NULL
,	NULL
Van	NULL
Snick	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Uyttenhove	NULL
,	NULL
C.	NULL
(	NULL
1993	NULL
)	NULL
Adv	NULL
.	NULL

Immunol	NULL
.	NULL

54	NULL
,	NULL
79-97	NULL
2	NULL
.	NULL

Yang	NULL
,	NULL
Y.-C.	NULL
,	NULL
Ricciardi	NULL
,	NULL
S.	NULL
,	NULL
Ciarletta	NULL
,	NULL
A.	NULL
,	NULL
Calvetti	NULL
,	NULL
J.	NULL
,	NULL
Kelleher	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Clark	NULL
,	NULL
S.	NULL
C.	NULL
(	NULL
1989	NULL
)	NULL
Blood	NULL
74	NULL
,	NULL
1880-1884	NULL
3	NULL
.	NULL

Renauld	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Goethals	NULL
,	NULL
A.	NULL
,	NULL
Houssiau	NULL
,	NULL
F.	NULL
,	NULL
Merz	NULL
,	NULL
H.	NULL
,	NULL
Van	NULL
Roost	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Van	NULL
Snick	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

144	NULL
,	NULL
4235-4241	NULL
4	NULL
.	NULL

Uyttenhove	NULL
,	NULL
C.	NULL
,	NULL
Simpson	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Van	NULL
Snick	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

85	NULL
,	NULL
6943-6948	NULL
5	NULL
.	NULL

Petit-frere	NULL
,	NULL
C.	NULL
,	NULL
Dugas	NULL
,	NULL
B.	NULL
,	NULL
Braquet	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Mencia-Huerta	NULL
,	NULL
J.	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Immunology	NULL
79	NULL
,	NULL
146-151	NULL
6	NULL
.	NULL

Dugas	NULL
,	NULL
B.	NULL
,	NULL
Renauld	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Pene	NULL
,	NULL
J.	NULL
,	NULL
Bonneloy	NULL
,	NULL
J.	NULL
Y.	NULL
,	NULL
Petit-frere	NULL
,	NULL
C.	NULL
,	NULL
Braquet	NULL
,	NULL
P.	NULL
,	NULL
Bousguet	NULL
,	NULL
J.	NULL
,	NULL
Van	NULL
Snick	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Mencia-Huerta	NULL
,	NULL
J.	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Kur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

28	NULL
,	NULL
1687-1692	NULL
7	NULL
.	NULL

Hultner	NULL
,	NULL
L.	NULL
,	NULL
Moeller	NULL
,	NULL
J.	NULL
,	NULL
Schmitt	NULL
,	NULL
E.	NULL
,	NULL
Jager	NULL
,	NULL
G.	NULL
,	NULL
Reisbach	NULL
,	NULL
G.	NULL
,	NULL
Ring	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Dormer	NULL
,	NULL
P.	NULL
(	NULL
1989	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

142	NULL
,	NULL
3440-3446	NULL
8	NULL
.	NULL

Hultner	NULL
,	NULL
L.	NULL
,	NULL
Druez	NULL
C.	NULL
,	NULL
Moeller	NULL
,	NULL
J.	NULL
,	NULL
Uyttenhove	NULL
,	NULL
C.	NULL
,	NULL
Schmitt	NULL
,	NULL
E.	NULL
,	NULL
Rude	NULL
,	NULL
E.	NULL
,	NULL
Dormer	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Van	NULL
Snick	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

20	NULL
,	NULL
1413-1416	NULL
9	NULL
.	NULL

Williams	NULL
,	NULL
D.	NULL
E.	NULL
,	NULL
Morrissey	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
Mochizuki	NULL
,	NULL
D.	NULL
Y.	NULL
,	NULL
de	NULL
Vries	NULL
,	NULL
P.	NULL
,	NULL
Anderson	NULL
,	NULL
D.	NULL
,	NULL
Cosman	NULL
,	NULL
D.	NULL
,	NULL
Boswell	NULL
,	NULL
H.	NULL
S.	NULL
,	NULL
Cooper	NULL
,	NULL
S.	NULL
,	NULL
Grabstein	NULL
,	NULL
K.	NULL
H.	NULL
,	NULL
and	NULL
Broxmeyer	NULL
,	NULL
H.	NULL
E.	NULL
(	NULL
1990	NULL
)	NULL
Blood	NULL
76	NULL
,	NULL
906-911	NULL
10	NULL
.	NULL

Donahue	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
Yang	NULL
,	NULL
Y.-C.	NULL
,	NULL
and	NULL
Clark	NULL
,	NULL
S.	NULL
C.	NULL
(	NULL
1990	NULL
)	NULL
Blood	NULL
75	NULL
,	NULL
2271-2275	NULL
11	NULL
.	NULL

Suda	NULL
,	NULL
T.	NULL
,	NULL
Murray	NULL
,	NULL
R.	NULL
,	NULL
Fischer	NULL
,	NULL
M.	NULL
,	NULL
Yokota	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Zlotnik	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

144	NULL
,	NULL
1783-1787	NULL
12	NULL
.	NULL

Merz	NULL
,	NULL
H.	NULL
,	NULL
Houssiau	NULL
,	NULL
F.	NULL
A.	NULL
,	NULL
Orscheschek	NULL
,	NULL
K.	NULL
,	NULL
Renauld	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Fliedner	NULL
,	NULL
A.	NULL
,	NULL
Herin	NULL
,	NULL
M.	NULL
,	NULL
Noel	NULL
,	NULL
H.	NULL
,	NULL
Kadin	NULL
,	NULL
M.	NULL
,	NULL
Mueller-Hermelink	NULL
,	NULL
H.	NULL
K.	NULL
,	NULL
Van	NULL
Snick	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Feller	NULL
,	NULL
A.	NULL
C.	NULL
(	NULL
1991	NULL
)	NULL
Blood	NULL
78	NULL
,	NULL
1311-1317	NULL
13	NULL
.	NULL

Gruss	NULL
,	NULL
H.	NULL
J.	NULL
,	NULL
Brach	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Drexler	NULL
,	NULL
H.	NULL
G.	NULL
,	NULL
Bross	NULL
,	NULL
K.	NULL
J.	NULL
,	NULL
and	NULL
Herrmann	NULL
,	NULL
F.	NULL
(	NULL
1992	NULL
)	NULL
Cancer	NULL
Res	NULL
.	NULL

52	NULL
,	NULL
1026-1031	NULL
14	NULL
.	NULL

Vink	NULL
,	NULL
A.	NULL
,	NULL
Renauld	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Warnier	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Van	NULL
Snick	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

28	NULL
,	NULL
1134-1138	NULL
15	NULL
.	NULL

Renauld	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Vink	NULL
,	NULL
A.	NULL
,	NULL
Louahed	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Van	NULL
Snick	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Blood	NULL
85	NULL
,	NULL
Transcriptional	NULL
Regulation	NULL
of	NULL
IL-9	NULL
Gene	NULL
Expression	NULL
1300-1305	NULL
16	NULL
.	NULL

Renauld	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
van	NULL
der	NULL
Lugt	NULL
,	NULL
N.	NULL
,	NULL
Vink	NULL
,	NULL
A.	NULL
,	NULL
van	NULL
Roon	NULL
,	NULL
M.	NULL
,	NULL
Godfraind	NULL
,	NULL
C.	NULL
,	NULL
Warnier	NULL
,	NULL
G.	NULL
,	NULL
Merz	NULL
,	NULL
H.	NULL
,	NULL
Feller	NULL
,	NULL
A.	NULL
,	NULL
Berns	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Van	NULL
Snick	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Oncogene	NULL
9	NULL
,	NULL
1327-1332	NULL
17	NULL
.	NULL

Mock	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
Krall	NULL
,	NULL
M.	NULL
,	NULL
Kozak	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Nesbitt	NULL
,	NULL
M.	NULL
N.	NULL
,	NULL
McBride	NULL
,	NULL
O.	NULL
W.	NULL
,	NULL
Renauld	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
and	NULL
Van	NULL
Snick	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Immunogenetics	NULL
81	NULL
,	NULL
265-270	NULL
18	NULL
.	NULL

Kelleher	NULL
,	NULL
K.	NULL
,	NULL
Bean	NULL
,	NULL
K.	NULL
,	NULL
Clark	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
Leung	NULL
,	NULL
W.-Y	NULL
.	NULL

,	NULL
Yang-Feng	NULL
,	NULL
T.	NULL
L.	NULL
,	NULL
Chen	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Lin	NULL
,	NULL
P.-F.	NULL
,	NULL
Luo	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
Yang	NULL
,	NULL
Y.-C.	NULL
(	NULL
1991	NULL
)	NULL
Blood	NULL
77	NULL
,	NULL
1436-1441	NULL
19	NULL
.	NULL

Furth	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Greaves	NULL
,	NULL
M.	NULL
(	NULL
1989	NULL
)	NULL
Cancer	NULL
Cells	NULL
:	NULL
Molecular	NULL
Diagnostics	NULL
of	NULL
Human	NULL
Cancer	NULL
,	NULL
p.	NULL
58	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
NY	NULL
20	NULL
.	NULL

Minty	NULL
,	NULL
A.	NULL
,	NULL
Chalon	NULL
,	NULL
P.	NULL
,	NULL
Derocq	NULL
,	NULL
J.-M.	NULL
,	NULL
Dumont	NULL
,	NULL
X.	NULL
,	NULL
Guillemot	NULL
,	NULL
J.-C.	NULL
,	NULL
Kaghad	NULL
,	NULL
M.	NULL
,	NULL
Labit	NULL
,	NULL
C.	NULL
,	NULL
Leplatois	NULL
,	NULL
P.	NULL
,	NULL
Liauzun	NULL
,	NULL
P.	NULL
,	NULL
Miloux	NULL
,	NULL
B.	NULL
,	NULL
Minty	NULL
,	NULL
C.	NULL
,	NULL
Casellas	NULL
,	NULL
P.	NULL
,	NULL
Loison	NULL
,	NULL
G.	NULL
,	NULL
Lupker	NULL
,	NULL
J.	NULL
,	NULL
Shire	NULL
,	NULL
D.	NULL
,	NULL
Ferrara	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Caput	NULL
,	NULL
D.	NULL
(	NULL
1993	NULL
)	NULL
Nature	NULL
862	NULL
,	NULL
248-250	NULL
21	NULL
.	NULL

Miyatake	NULL
,	NULL
S.	NULL
,	NULL
Seiki	NULL
,	NULL
M.	NULL
,	NULL
Yoshida	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Arai	NULL
,	NULL
K.-L.	NULL
(	NULL
1988	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8	NULL
,	NULL
5581-5587	NULL
22	NULL
.	NULL

Miyatake	NULL
,	NULL
S.	NULL
,	NULL
Shlomai	NULL
,	NULL
J.	NULL
,	NULL
Arai	NULL
,	NULL
K.-I	NULL
.	NULL

,	NULL
and	NULL
Arai	NULL
,	NULL
N.	NULL
(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11	NULL
,	NULL
5894-5901	NULL
23	NULL
.	NULL

Chomezynski	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Sacchi	NULL
,	NULL
N.	NULL
(	NULL
1987	NULL
)	NULL
Anal	NULL
.	NULL

Biochem	NULL
.	NULL

162	NULL
,	NULL
156-159	NULL
24	NULL
.	NULL

Lord	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
Abdollahi	NULL
,	NULL
A.	NULL
,	NULL
Thomas	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
DeMacro	NULL
,	NULL
M.	NULL
,	NULL
Brugge	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
Hoffman-Liebermann	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Liebermann	NULL
,	NULL
D.	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11	NULL
,	NULL
4371-4379	NULL
25	NULL
.	NULL

Sambrook	NULL
,	NULL
J.	NULL
,	NULL
Fritsch	NULL
,	NULL
E.	NULL
F.	NULL
,	NULL
and	NULL
Maniatis	NULL
,	NULL
T.	NULL
(	NULL
1989	NULL
)	NULL
Molecular	NULL
Cloning	NULL
:	NULL
A	NULL
Laboratory	NULL
Manual	NULL
2nd	NULL
Ed	NULL
.	NULL

,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
NY	NULL
26	NULL
.	NULL

Zinn	NULL
,	NULL
K.	NULL
,	NULL
DiMaio	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Maniatis	NULL
,	NULL
T.	NULL
(	NULL
1983	NULL
)	NULL
Cell	NULL
84	NULL
,	NULL
865-879	NULL
27	NULL
.	NULL

Nordeen	NULL
,	NULL
S.	NULL
K.	NULL
(	NULL
1988	NULL
)	NULL
BioTechniques	NULL
6	NULL
,	NULL
454-458	NULL
28	NULL
.	NULL

Dignam	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Lebovitz	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
and	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1983	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11	NULL
,	NULL
1475-1489	NULL
29	NULL
.	NULL

Lenardo	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Kuang	NULL
,	NULL
A.	NULL
,	NULL
Gifford	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

85	NULL
,	NULL
8825-8829	NULL
30	NULL
.	NULL

Li	NULL
,	NULL
C.	NULL
C.	NULL
,	NULL
Korner	NULL
,	NULL
M.	NULL
,	NULL
Ferris	NULL
,	NULL
D.	NULL
K.	NULL
,	NULL
Chen	NULL
,	NULL
E.	NULL
,	NULL
Dai	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
and	NULL
Longo	NULL
,	NULL
D.	NULL
L.	NULL
(	NULL
1994	NULL
)	NULL
Biochem	NULL
.	NULL

J	NULL
.	NULL

808	NULL
,	NULL
499-506	NULL
31	NULL
.	NULL

Szabo	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Gold	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
Murphy	NULL
,	NULL
T.	NULL
L.	NULL
,	NULL
and	NULL
Murphy	NULL
,	NULL
K.	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
4793-4850	NULL
32	NULL
.	NULL

Bokar	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Keri	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Farmerie	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
Fenstermaker	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Anderson	NULL
,	NULL
B.	NULL
,	NULL
Hamernik	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
Yun	NULL
,	NULL
J.	NULL
,	NULL
Wagner	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Nilson	NULL
,	NULL
J.	NULL
H.	NULL
(	NULL
1989	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9	NULL
,	NULL
5113-5122	NULL
33	NULL
.	NULL

Muegge	NULL
,	NULL
K.	NULL
,	NULL
Williams	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
Kant	NULL
,	NULL
J.	NULL
,	NULL
Karin	NULL
,	NULL
M.	NULL
,	NULL
Chiu	NULL
,	NULL
A.	NULL
,	NULL
Schimid	NULL
,	NULL
A.	NULL
,	NULL
Siebenlist	NULL
,	NULL
U.	NULL
,	NULL
Young	NULL
,	NULL
H.	NULL
A.	NULL
,	NULL
and	NULL
Durum	NULL
,	NULL
S.	NULL
K.	NULL
(	NULL
1989	NULL
)	NULL
Science	NULL
246	NULL
,	NULL
249-251	NULL
34	NULL
.	NULL

Mathey-Prevot	NULL
,	NULL
B.	NULL
,	NULL
Andrews	NULL
,	NULL
N.	NULL
C.	NULL
,	NULL
Murphy	NULL
,	NULL
H.	NULL
S.	NULL
,	NULL
Kreissman	NULL
,	NULL
S.	NULL
G.	NULL
,	NULL
and	NULL
Nathan	NULL
,	NULL
D.	NULL
G.	NULL
(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

87	NULL
,	NULL
5046-5050	NULL
35	NULL
.	NULL

Chuypilo	NULL
,	NULL
S.	NULL
,	NULL
Schomberg	NULL
,	NULL
C.	NULL
,	NULL
Gerwig	NULL
,	NULL
R.	NULL
,	NULL
Heinfling	NULL
,	NULL
A.	NULL
,	NULL
Reeves	NULL
,	NULL
R.	NULL
,	NULL
Grummt	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Serfling	NULL
,	NULL
E.	NULL
(	NULL
1993	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

21	NULL
,	NULL
5694-5704	NULL
36	NULL
.	NULL

Lee	NULL
,	NULL
H.	NULL
J.	NULL
,	NULL
Masuda	NULL
,	NULL
E.	NULL
S.	NULL
,	NULL
Arai	NULL
,	NULL
N.	NULL
,	NULL
Arai	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Yokota	NULL
,	NULL
T.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
17541-17550	NULL
37	NULL
.	NULL

Jenkins	NULL
,	NULL
F.	NULL
,	NULL
Cockerill	NULL
,	NULL
P.	NULL
N.	NULL
,	NULL
Bohmann	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Shannon	NULL
,	NULL
M.	NULL
F.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

155	NULL
,	NULL
1240-1251	NULL
38	NULL
.	NULL

Hoyos	NULL
,	NULL
B.	NULL
,	NULL
Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Boohnlein	NULL
,	NULL
E.	NULL
,	NULL
Siekevitz	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1989	NULL
)	NULL
Science	NULL
244	NULL
,	NULL
457-460	NULL
39	NULL
.	NULL

Libermann	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
2327-2334	NULL
40	NULL
.	NULL

Collart	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Baeuerle	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Vassalli	NULL
,	NULL
P.	NULL
(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
1498-1506	NULL
41	NULL
.	NULL

Shreck	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
1281-1286	NULL
42	NULL
.	NULL

Naora	NULL
,	NULL
H.	NULL
,	NULL
Van	NULL
,	NULL
C.	NULL
B.	NULL
,	NULL
Bourke	NULL
,	NULL
P.	NULL
F.	NULL
,	NULL
and	NULL
Young	NULL
,	NULL
I.	NULL
G.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

153	NULL
,	NULL
3466-3475	NULL
43	NULL
.	NULL

Siegel	NULL
,	NULL
M.	NULL
D.	NULL
,	NULL
Zhang	NULL
,	NULL
D.-H.	NULL
,	NULL
Ray	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Ray	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
24548-24555	NULL
44	NULL
.	NULL

Orkin	NULL
,	NULL
S.	NULL
H.	NULL
(	NULL
1992	NULL
)	NULL
Blood	NULL
80	NULL
,	NULL
575-581	NULL
45	NULL
.	NULL

Arceci	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
King	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
Simon	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
Orkin	NULL
,	NULL
S.	NULL
H.	NULL
,	NULL
and	NULL
Wilson	NULL
,	NULL
D.	NULL
B	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
2235-2246	NULL
46	NULL
.	NULL

Yamamoto	NULL
,	NULL
M.	NULL
,	NULL
Ko	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
Leonard	NULL
,	NULL
M.	NULL
W.	NULL
,	NULL
Beug	NULL
,	NULL
H.	NULL
,	NULL
Orkin	NULL
,	NULL
S.	NULL
H.	NULL
,	NULL
and	NULL
Engel	NULL
,	NULL
J.	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

4	NULL
,	NULL
1650-1662	NULL
47	NULL
.	NULL

Ho	NULL
,	NULL
I.	NULL
C.	NULL
,	NULL
Vorhees	NULL
,	NULL
P.	NULL
,	NULL
Marin	NULL
,	NULL
N.	NULL
,	NULL
Okaley	NULL
,	NULL
B.	NULL
K.	NULL
,	NULL
Tsai	NULL
,	NULL
S.	NULL
F.	NULL
,	NULL
Orkin	NULL
,	NULL
S.	NULL
H.	NULL
,	NULL
and	NULL
Leiden	NULL
,	NULL
J.	NULL
M.	NULL
(	NULL
1991	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

10	NULL
,	NULL
1187-1192	NULL
48	NULL
.	NULL

Ko	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
Yamamoto	NULL
,	NULL
M.	NULL
,	NULL
Leonard	NULL
,	NULL
M.	NULL
W.	NULL
,	NULL
George	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
Ting	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Engel	NULL
,	NULL
J.	NULL
D.	NULL
(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11	NULL
,	NULL
2778-2784	NULL
49	NULL
.	NULL

Kaushansky	NULL
,	NULL
K.	NULL
,	NULL
Shoemaker	NULL
,	NULL
S.	NULL
G.	NULL
,	NULL
O'Rork	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
and	NULL
McCarty	NULL
,	NULL
J.	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

152	NULL
,	NULL
1812-1820	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Multiple	NULL
Transcription	NULL
Factors	NULL
Are	NULL
Required	NULL
for	NULL
Activation	NULL
of	NULL
Human	NULL
Interleukin	NULL
9	NULL
Gene	NULL
in	NULL
T	NULL
Cells	NULL
Yuan	NULL
Xiao	NULL
Zhu	NULL
,	NULL
Li	NULL
Ya	NULL
Kang	NULL
,	NULL
Wen	NULL
Luo	NULL
,	NULL
Chou-Chi	NULL
H.	NULL
Li	NULL
,	NULL
Liu	NULL
Yang	NULL
and	NULL
Yu-Chung	NULL
Yang	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

1996	NULL
,	NULL
271:15815-15822.	NULL
doi	NULL
:	NULL
10.1074/jb0.271.26.15815	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
http	NULL
:	NULL
/www.jbe.org/content/271/26/15815	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
47	NULL
references	NULL
,	NULL
32	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
4q	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL

